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Abstract
Although cocaine and other psychostimulants are highly rewarding, they also produce
aversive effects that influence drug-seeking, and that are stronger in some individuals than
others for poorly understood reasons. We now find in rats that cocaine depolarizes neurons of
the rostromedial tegmental nucleus (RMTg), a major GABAergic afferent to midbrain dopamine
neurons, and a driver of punishment learning. This activation is mediated by post-synaptic
serotonin 2C receptors, and is particularly strong in subsets of animals having heightened
aversive responses to cocaine, among whom it slows the initial acquisition of cocaine selfadministration and reduced cue-induced relapse for cocaine after extinction. These resilience
phenotypes are lost upon delivery into RMTg, but not adjacent sites, of 5-HT2CR antagonist or
shRNA-mediated knockdown of this receptor. Hence, 5-HT2CRs in RMTg may contribute to
innate, and individually variable, protection against cocaine-seeking.
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Chapter 1
General Introduction
1.1 Substance Use Disorders are Behavioral Addiction Disorders
Colloquially, the term “addiction” is often used to refer to the excessive engagement
with almost any typically rewarding and habitual behaviors such as drug use, gambling, internet
and smartphone use, TV watching, playing video games, shopping, sex, eating, and exercise.
Medically, however, the most well-defined addictive disorders are still those related to various
substances or drugs. In the DSM-5 section of Substance-Related and Addictive Disorders,
substance use disorders (SUDs) are diagnosed and evaluated based on symptoms or descriptors
related to failed attempts to cut down, use in risky situations and despite negative
consequences, failure to fulfill work, family, and social responsibilities, and the emergence of
physical dependence. These diagnostic criteria reflect the behavioral nature of addictive
disorders and suggest successful treatment may result from reversing or opposing cognitive
processes and neural mechanisms that foster and reinforce compulsive substance use.
1.2 The Cost of Substance Use Disorders
The reach and cost of SUDs are tremendous in many aspects and on multiple levels
worldwide. According to the World Drug Report 2020, in the past year the top five most used
drugs globally were cannabis, opioids, amphetamines and prescription stimulants, ecstasy, and
cocaine with 192, 58, 27, 21, and 19 million users, respectively. In 2018, approximately 269
million people worldwide used drugs at least once, corresponding to about 1 in every 19
people, and 35.6 million were estimated to suffer from drug use disorders, corresponding to a
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comprehensive prevalence of drug use disorders of 0.7% among the population aged 15-64.
SUDs increase incidences of overdose and infectious diseases such as HIV and hepatitis (Kandel,
Yamaguchi and Chen 1992), and it is typically associated with comorbid psychiatric disorders
(NIDA 2018 common comorbidities with SUD) and social disadvantages such as low educational
attainment, increased difficulty with employment, and financial instability and poverty. The
negative consequences of drug use can extend beyond individuals to impact the well-being and
culture of the immediate family, neighborhood, and community (Lander, Howsare and Byrne
2013, Edalati and Krank 2016). According to the Global Burden of Disease Study, in 2017 there
were estimated 42 million years of healthy life lost because of disability and premature death,
and a total 585,000 deaths attributed to the use of drugs. According to the US National Institute
of Drug Abuse (NIDA), in costs related to crime, lost work productivity, and health care,
tobacco, alcohol, illicit drugs, and prescription opioids exact $300, $249, $193, and $78.5
billions based on year 2010, 2010, 2007, and 2013, respectively.
1.3 The Central Role of the Midbrain Dopamine System in Reinforcement and Drug Addiction
Presently, SUDs are recalcitrant disorders with limited effective treatment options.
According to a NIDA estimate from 2018, 40-60% of drug addiction patients relapse. There is
only a small number of pharmacological agents that are specifically approved for treating
substance abuse and addiction, and inpatient or outpatient rehabilitation program cost can be
exorbitant. A better understanding of SUDs’ biological underpinning may lead to more effective
and cost-efficient therapies.
Numerous CNS alterations have been identified in addicted brains. Functional MRIs have
found many brain regions, such as the nucleus accumbens, ventral pallidum, orbitofrontal
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cortex, subcallosal cortex, amygdala, hippocampus, prefrontal cortex, and the anterior
cingulate gyrus, that showed specific and particular responses to drugs and associated cues
(Stein et al. 1998, Schultz, Tremblay and Hollerman 2000), and PET studies have shown effects
of chronic drug exposure on receptors, metabolic enzymes, and transporters involved in
dopamine neurotransmission (Volkow et al. 2001, Fowler et al. 1996). These findings and others
have led to the disease model of SUDs, which posits drugs exert their reinforcing effects
through the dopamine system, and that deregulation of brain circuits involved in natural
reward, motivation, memory and impulse control is related to maladaptive DA
neurotransmission subsequent to chronic activation and excitation by drugs of abuse (Volkow,
Fowler and Wang 2003, Koob and Bloom 1988).
The implication of the midbrain dopamine system in behavioral addiction to drugs is
significant because more than half a century of tremendous interest and research have shown
and positioned dopamine and dopamine neurons to be central drivers in the neural
mechanisms of reinforcement. As early as the 1950s it was found that rodents readily acquired
and eagerly maintained intracranial self-stimulation (ICSS) of the medial forebrain bundle (MFB)
(Olds and Milner 1954), and that brain stimulation reward was attenuated by dopamine
blockers independent of the animals’ ability to perform the operant response (Fouriezos and
Wise 1976, Fouriezos, Hansson and Wise 1978, Franklin and McCoy 1979). It was deduced that
the ascending fibers from dopaminergic neurons were probably not the direct target of ICSS,
but rather the descending myelinated fibers passing through the hypothalamus and terminating
at dopamine neurons of the VTA and substantia nigra pars compacta (SNc) (Shizgal et al. 1980).
In basal conditions, dopamine neurons of the VTA have been found to fire action potentials
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from ~0.5 to ~10 Hz with the majority of cells firing around 4-5 Hz in both anesthetized and
awake adult rats (Grace and Bunney 1984b). The firing pattern is interspersed with clusters of
action potentials emitted at high frequency (~2-5 spikes at approximately 10-20 Hz) commonly
known as “bursts” (Grace and Bunney 1984a). DA neuron bursting is significant because it
transiently increases dopamine to high concentrations that are required to activate postsynaptic dopamine receptors, and they occur in response to stimulation of dopamine cell
bodies, administration of drugs, and behaviorally salient events (Marinelli and McCutcheon
2014). It has been demonstrated at the striatum, which is the primary forebrain target of
dopamine, the co-occurrence of glutamate stimulation of a striatal dendrite spine, postsynaptic
depolarization, and transient dopamine release and increase caused the spine to grow
(Yagishita et al. 2014). By virtue of its rapid response to rewarding stimuli, projections to
circuits important for motivated behaviors, and ability to cause synaptic plastic changes, the
midbrain dopamine system is hypothesized to mediate reinforcement by attributing or
increasing salience of recently rewarding stimuli, updating the value of recently performed
actions, potentiating synapses that link representation of the current state to specific
behaviors, and biasing and invigorating actions that increase the likelihood of reward (Wickens
et al. 2007, Berke 2018).
Consistent with the dopamine system’s important functions in reinforcement and
aberrant DA neurotransmission observed in SUDs, many studies have indeed found drugs’
reinforcing effects are correlated with or causally linked to dopamine release and dopamine
neuron activity. Many drugs of abuse have been shown to alter catecholamine synaptic activity.
Amphetamine causes catecholamine release, and cocaine inhibits catecholamine inactivation
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by reuptake (Heikkila, Orlansky and Cohen 1975). In self-administration studies where animal
subjects performed operant lever-pressing response to initiate and maintain drug delivery, in
vivo microdialysis found increases in extracellular DA in the nucleus accumbens during
psychostimulant (Meil et al. 1995, Pontieri, Tanda and Di Chiara 1995, Wise et al. 1995b), opiate
(Hemby et al. 1995, Wise et al. 1995a), nicotine (Pontieri et al. 1996, Lecca et al. 2006),
cannabinoids (Fadda et al. 2006), and ethanol self-administration (Melendez et al. 2002, van
Erp and Miczek 2007). The causal relationship between dopamine level or receptor activation
and reinforcement of operant behavior for drugs was corroborated from studies showing
systemic DA synthesis inhibitors or DA receptor antagonists (Pickens, Meisch and Dougherty
1968, Wilson and Schuster 1974, Yokel and Wise 1975, Rassnick, Pulvirenti and Koob 1992,
Richardson, Smith and Roberts 1994) and 6-hydroxydopamine mediated lesion of DA terminals
in the nucleus accumbens (Lyness, Friedle and Moore 1979, Corrigall et al. 1992) reduced the
self-administration of psychostimulants, opiates, nicotine, and ethanol. In addition to causing
synaptic dopamine release, drugs may also activate dopamine neurons directly. Animals reliably
self-administered intracranial microinjections of drugs of abuse including psychostimulants,
opiates, and ethanol into the VTA (Rodd et al. 2005, Gatto et al. 1994, Bozarth and Wise 1981).
In addition to evidences of necessity, the VTA dopamine neurons were further demonstrated to
be sufficient for compulsivity, when it was found that optogenetic activation of DA neurons in
the midbrain induced place preference, reinforced instrumental behaviors, and in some cases,
caused operant response that persisted in spite of negative consequences (Tsai et al. 2009,
Adamantidis et al. 2011, Witten et al. 2011, Kim et al. 2012, Rossi et al. 2013, Ilango et al. 2014,
Pascoli et al. 2015). Altogether, these evidences demonstrate drugs of abuse and operant
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behavior for drugs activate the DA system and potentiate its output, which in turn fosters and
strengthens the formation of neuroplasticity that underlies and further perpetuates reward
seeking habits and motor programs. They suggest a further understanding of neural
mechanisms or affects that may be oppositional to the DA system and appetitive behavior is a
viable avenue for developing therapeutic strategies.
1.4 The Aversive Effects of Drugs and the Opponent Process Theory
In spite of drugs’ significant addictive potential, however, only a proportion, 3.7-31.9%,
of human users become addicted (Anthony et al. 1994, Merikangas and McClair 2012).
Individual vulnerability to addiction is likely determined by a multitude of host and
environmental factors and the subjective experiential effects of substances of abuse (Stone et
al. 2012, Uhl 2004, Wong and Schumann 2008, Kreek et al. 2005, Kreek et al. 2012). While it is
generally accepted that drug taking is initially driven by the desire to experiment with or
experience drug’s positively or negatively (e.g. anxiety reduction) rewarding effects, there is
growing recognition and interest in the role of the aversive effects of drugs in modulating drug
taking (Goudie 1979, Gaiardi et al. 1991, Verendeev and Riley 2012, Verendeev and Riley 2013).
Specifically, accumulating evidence suggests drug aversive effects may influence the course and
outcome of substance use in a stage-dependent manner. For naïve or relatively inexperienced
users that are susceptible, immediate adverse reactions or aversive effects may deter further
drug use. For example, Asian Americans that exhibit more acute adverse reactions to alcohol
due to a mutation in the aldehyde dehydrogenase (ALDH2) gene have been found to show
lower rates of alcohol use and alcoholism (Wall et al. 2000, Luczak et al. 2006), and anxiety,
paranoia, and sensations of near fainting have been reported to deter some users from further
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use of stimulant (Williamson et al. 1997). On the other hand, for chronic or abstinent users who
exhibit tolerance and withdrawal symptoms, however, protracted aversive effects such as
anxiety, depression, craving, agitation, dysphoria, and anhedonia that are common to many
substances of abuse may instead contribute to further drug use and relapse (Gawin and Kleber
1986, Louie et al. 1996, Paine, Jackman and Olmstead 2002, Kenny and Markou 2001, Molas et
al. 2017, Swift and Stout 1992, Saitz 1998, Koob et al. 1989, Wheeler et al. 2008, Wheeler et al.
2015, Riley 2011, Verendeev and Riley 2013). Evidently, there appears to be individual
differences in susceptibility to the aversive effects of drugs, and while different drugs elicit
variegated initial adverse reactions, withdrawal and anhedonic symptoms that present similarly
suggest there may be common neural substrates or mechanisms that underlie drug aversive
effects. A better understanding of drugs’ aversive effects may lead to insight into motivation for
drugs, biomarkers that predict addiction propensity, personalized counseling and treatment,
and possible therapeutic targets, as in the case of disulfiram (Antabuse), which inhibits ADLH2
to reduce alcohol intake by greatly potentiating its aversive effects.
While the causes or mechanisms of many drug aversive effects are not well understood,
they are posited to result from processes that oppose initial drug rewarding effects. In the
1970s Solomon and Corbit developed the opponent process theory which proposes many
empirically observed phenomenology of affective responses to both rewarding and aversive
stimuli, drugs included, may be organized and investigated in terms of a few ruling principles
(Solomon and Corbit 1974). First, the theory proposes any hedonic, affective, or emotional
state that occurs in response to an arousing stimulus is followed by an after-reaction that is
delayed but opposite in motivational valence. Second, it is conjectured that the immediate
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reaction and after-reaction are mediated by discrete neural processes or mechanisms, e.g.,
“process A” and “process B”. Third, the overall subjective experience of the arousing stimulus is
the product of summation between “process A” and “process B”. Fourth, for reasons not well
understood but based on empirical observations of affective responses, upon repeated affectarousing stimulations, while “process A” remains relatively unchanged in magnitude, the
opponent “process B” becomes strengthened. These “rules” may be applied to explain many
phenomena or affective responses associated with substance abuse and addiction such as
“crash”, tolerance, prolonged withdrawal, and relapse, and the opponent-process provides a
conceptual framework for examining and testing the role or function of neural substrates that
may be hypothesized to underlie or contribute to drug aversive effects.
1.5 The Role and Neurobiology of the Serotonin System in Motivated Behavior, Affects, and
Regulation of the Dopamine System
The opponent process theory hypothesizes the biphasic dynamics and the bivalent
motivational properties of affective responses are mediated by discrete neural mechanisms.
Anatomical and pharmacological evidence suggests that the ventral tegmental and substantia
nigra dopamine system and the raphe serotonin system may act as mutual opponents (Fletcher
1995, Fletcher 1991, Fletcher, Korth and Chambers 1999, Kapur and Remington 1996). While
the dopamine system’s functions and anatomy involved in reinforcement learning and motor
invigoration have been intensely researched and elucidated, owing to a more united framework
and vantage point of understanding it in terms of reward learning, the roles, mechanisms of
action, and the neural substrates involved of serotonin in motivated behaviors are much less
clear. It has been proposed that the serotonin neuromodulator is involved in either of or two
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functions analogous but opposite to those of DA: aversive processing (Deakin and Graeff 1991)
and behavioral inhibition (Soubrie 1986). Clinically it has been found that serotonin metabolites
in cerebrospinal fluid are decreased in impulsive disorders including impulsive aggression,
violence, and mania (Linnoila et al. 1983, Linnoila and Virkkunen 1992), which are characterized
by both behavioral disinhibition and reduced aversive processing. On the other hand, it has
been suggested that increasing serotonin with selective serotonin reuptake inhibitors (SSRIs)
might show therapeutic benefit for impulse control disorders such as pathological gambling,
sexual addiction, and personality disorders (Hollander and Rosen 2000). Experimental findings
have shown that aversive stimuli activate serotonergic neurons (Takase et al. 2004), and
depletion of central serotonin disinhibits responses that are punished by aversive outcome
(Soubrie 1986). In particular, intracerebroventricular infusion of 5,7-dihydroxytryptamine (5,7DHT) increases premature response on the five-choice reaction-time task (5CSRTT) (Harrison,
Everitt and Robbins 1997, Harrison, Everitt and Robbins 1999), transgenic animals that lack the
serotonin transporter and exhibit enhanced serotonin transmission display reduced premature
responding on the 5CSRTT (Homberg et al. 2007), and depletion of the serotonin precursor
tryptophan by dietary acute tryptophan depletion (ATD) in nonhuman primates induces risky
decision making on a gambling task (Evenden 1999, Long, Kuhn and Platt 2009). The behavioral
inhibitory function or role of the serotonin system is apparent or can be inferred from
paradigms that do not operationally involve punishment as well. Systemic manipulation of
serotonin level via dietary tryptophan supplementation and neurotoxic lesion of serotonergic
neurons resulted in attenuation and enhancement, respectively, of operant response aimed at
obtaining natural or psychoactive reinforcers (Carroll et al. 1990a, Roberts et al. 1994).
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Furthermore, in a series of studies that tested the effects of agonists and antagonists of
dopamine and serotonin on unconditioned behaviors such as feeding and conditioned
behaviors such as responding for conditioned reward, self-administration, and conditioned
place preferences (Fletcher et al. 1999, Fletcher, Ming and Higgins 1993, Fletcher, Tampakeras
and Yeomans 1995), it was found that agonizing serotonin opposes conditioned and
unconditioned behaviors that are activated by dopamine, and agonizing dopamine or
antagonizing serotonin has the opposite effects.
Despite the wealth of clinical and experimental findings that implicate serotonin or the
serotonin system in aversive processing and behavioral inhibition, however, the association is
not perfect. For example, while dorsal raphe serotonergic neurons can be phasically activated
by pain (Schweimer and Ungless 2010), serotonin transporter positive (SERT+) DRN serotonin
neurons showed strong reward- but not aversion-related activity modulations in freely
behaving mice (Li et al. 2016), and stimulation of Pet-1 gene, which is selectively yet not
exclusively expressed in serotonergic neurons, positive DRN neurons was found to be highly
rewarding (Liu et al. 2014) . These seemingly conflicting findings may be explained by the corelease of glutamate in some serotonergic neurons, as direct targeting of VGluT3 neurons
projecting from DRN to VTA drove strong self-stimulation (Qi et al. 2014), the rewarding effect
of stimulating Pet-1 neurons was reduced in mice lacking VGlutT3 (Liu et al. 2014), and when
serotonin neurons were targeted via the regulatory elements of the rate-limiting enzyme in
serotonin synthesis, TpH2, no rewarding effects of stimulation were observed (Miyazaki et al.
2014).
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Serotonin neurons are located in midline nuclei of the brain stem. The dorsal raphe
nucleus (DRN) projects to the cortex, amygdala, striatum, thalamus, PAG, and hypothalamus,
while the median raphe nucleus (MRN) projects to the cortex, septal nuclei, hippocampus, and
hypothalamus (Azmitia and Segal 1978, O'Hearn and Molliver 1984, Geyer et al. 1976). The VTA
and the substantia nigra pars reticulata, the nucleus accumbens, and the ventromedial part of
the caudate nucleus receive dense serotonin projection, whereas the SNc and the rest of the
caudate nucleus are much less innervated (Lavoie and Parent 1990, Beart and McDonald 1982,
Herve et al. 1981, Herve et al. 1987). There is substantial experimental evidence that serotonin
regulates dopamine release (Esposito, Di Matteo and Di Giovanni 2008, Azmitia and Segal 1978,
Beart and McDonald 1982, Herve et al. 1987, Parent 1981, Geyer et al. 1976, Egerton et al.
2008, De Deurwaerdere et al. 2004, Higgins and Fletcher 2003, Lavoie and Parent 1990, Spoont
1992, Harrison et al. 1997, Nedergaard, Bolam and Greenfield 1988). There appears to be
diverse mechanisms and on many levels via which the DA system is regulated by the serotonin
system, for example, the bursting behavior of dopamine neurons may be reduced (Di Giovanni
et al. 1999), the relative balance between regional dopamine concentrations may be altered
(De Deurwaerdere and Spampinato 1999), and the projections that control dopamine release
may be modulated (Bortolozzi et al. 2005). It appears serotonin tonically regulate dopamine
release or metabolism in specific directions in a region- and receptor-specific manner. For
example, lesion of the MRN or DRN increases the metabolism of DA in the nucleus accumbens
but either reduces (MRN) or leaves unchanged (DRN) that of the PFC (Herve et al. 1981, Herve
et al. 1987). While 5-HT2C receptors in general has been found to tonically inhibit DA release,
however, other 5-HT receptor subtypes, 5-HT1A, 5-HT2A, 5-HT3, 5-HT4, stimulate DA release
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(Alex and Pehek 2007, Di Matteo et al. 2008, Higgins and Fletcher 2003). Further, serotonin
seems to exert an excitatory influence on the VTA (Beart and McDonald 1982, Van Bockstaele,
Cestari and Pickel 1994) and enhances dopamine release in the nucleus accumbens (Guan and
McBride 1989).
In summary, due to the existence of DRN serotonergic neurons that release mixed
neurotransmitters (serotonin, glutamate, and GABA), diverse serotonin receptor subtypes, preand postsynaptic localization of serotonin receptors, and wide-ranging distribution of serotonin
receptors in the CNS, DA level or function may be regulated by 5-HT neurotransmission in a
brain-region and receptor subtype specific manner, and the behavioral effects of 5-HT
neurotransmission may depend on the relative proportions of mixed versus pure
neurotransmitter-type neurons activated, the balance of heterogenous neurotransmitters
released, and the specific neural substrate or brain region(s) targeted. However, perhaps
especially in instances where mixed or glutamatergic raphe neurons are not involved or
activated, the serotonin system appears to mediate aversive processing and behavioral
inhibition, which are particularly evident in studies that involve global manipulation or
alteration of serotonin level or receptor function.
1.6 Cocaine’s Aversive Effects and the Role of the LHb-RMTg-VTA Pathway
Considering the prospective value of a better understanding of drug’s aversive effects
for treating addiction, the utility and applicability of the opponent process theory for
understanding drug’s bivalent properties, and the apparent function or role of serotonin in
aversive learning and inhibitory affects, cocaine may be a particularly suitable drug to study for
its aversive effects because of its relatively rapid, dynamic, and bivalent affective and
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motivational effects, and its effect of causing the accumulation of dopamine, norepinephrine,
and serotonin in nerve terminals and synapses. It has been found that many human users of
cocaine experience two distinct affective states of the drug upon administration: a relatively
rapid and intense euphoria followed by a state characterized by paranoia, anxiety, agitation,
depression, and craving for more cocaine (Anthony, Tien and Petronis 1989, Resnick and
Resnick 1984, Smith 1986, Washton and Tatarsky 1984, Williamson et al. 1997). Evidence of
cocaine’s negative or aversive effects has also been found in animal research studies. For
example, it was found that monkeys trained to lever-press for intravenous cocaine also learned
to press a second lever to terminate drug delivery (Spealman 1979). In rodents, cocaine has
been found to decease punished responding in a conflict test (Fontana and Commissaris 1989),
induce anxiety-like behavior in the elevated plus maze test (Rogerio and Takahashi 1992), and
increase latency to enter an open filed which is thought to reflect anxiety (Simon, Dupuis and
Costentin 1994, Yang et al. 1992). More recently, cocaine’s bidirectional motivational valence
property has been demonstrated in the runway operant self-administration paradigm
(Ettenberg 2004). In this task, animals are trained to traverse a straight 5-foot corridor to obtain
a single intravenous infusion of cocaine. It was found that over repeated training trials, many
animals develop an approach-avoidance conflict about entering the goal box. The conflict
behavior is characterized by a stop in forward locomotion, often at the mouth of the goal-box,
followed by a turn and retreat toward the home box. The conflicted motivation to both
approach and retreat from the cocaine-associated goal box is believed to stem from cocaine’s
bivalent motivational valences that can be demonstrated and isolated temporally. In a
conditioned place preference/aversion task, it was found that if an animal is exposed to the
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drug-paired chamber immediately after cocaine administration, place preference develops, but
if an animal is exposed to the drug-paired chamber at 15 minutes after cocaine exposure, place
aversion occurs instead (Ettenberg 2004, Jhou et al. 2013).
The mechanisms underlying cocaine’s aversive effects are not clear but have been
demonstrated to involve regulation of the dopamine system. Previously, it has been found that
acute cessation of cocaine intake results in accumbens dopamine level falling below baseline
(Weiss et al. 1992), and reduced accumbens DA signaling produces conditioned place aversion
(Shippenberg et al. 1991, Liu, Shin and Ikemoto 2008). While the exact mechanisms that
contribute to this post-cocaine DA reduction are not entirely clear, multiple lines of evidence
converge to indicate that the lateral habenula (LHb)-rostromedial tegmental nucleus (RMTg)VTA circuit plays a major role. The RMTg, which is located caudal and sends dense gabaergic
afferents to dopamine neurons of the VTA and SNc, is characterized by high expression of early
response gene proteins c-Fos and deltaFosB following cocaine exposure (Jhou 2005, Perrotti et
al. 2005, Jhou et al. 2009a, Jhou et al. 2009b, Kaufling et al. 2009, Balcita-Pedicino et al. 2011,
Jhou et al. 2013). The RMTg receives dense glutamatergic afferents from the LHb (Herkenham
and Nauta 1979, Jhou et al. 2009b, Kim 2009). Stimulation of either the LHb or RMTg inhibits
82-97% of DA neurons (Christoph, Leonzio and Wilcox 1986, Ji and Shepard 2007, Matsumoto
and Hikosaka 2007, Hong et al. 2011), and contributes to aversive conditioning (Lammel et al.
2012, Stamatakis and Stuber 2012). In a 2013 study, it was found that RMTg and LHb neurons
exhibit pronounced c-Fos after cocaine exposure, and lesion of the fasciculus retroflexus (FR)
and optogenetic inhibition of the RMTg following cocaine exposure abolishes cocaine’s ability
to condition avoidance behaviors in the runway operant paradigm. In spite of the positive
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behavioral effect, however, lesion of the FR, effectively eliminating LHb glutamatergic input to
the RMTg, abolishes only about 50% of RMTg c-Fos in response to cocaine. The source of the
other 50% excitatory input that contributes to RMTg excitation following cocaine exposure
remains unidentified.
1.7 5-HT2C Receptors and Operant Response Aimed at Cocaine Taking and Seeking
While dopamine’s role in mediating cocaine drug reward and reinforcement is well
established and accepted, prior studies found norepinephrine receptor antagonists showed no
effect on cocaine self-administration (Woolverton 1987) and implicated serotonin in opposing
the reinforcing effects of cocaine. Particularly, there is an extensive body of literature that
demonstrates the involvement of neurotransmission through the serotonin receptor family
member 5-HT2CR in the abuse-related effects of cocaine. Electrophysiological and microdialysis
studies have shown that systemic administration of selective 5-HT2CR agonists decreased,
whereas antagonists and inverse agonists increased basal firing rates of VTA DA neurons and
subsequent DA release within the NAc (Di Matteo et al. 1999, Di Giovanni et al. 2000).
Consistently, it has been found in 5-HT2CR knockout mice cocaine-induced increase of dopamine
(DA) was enhanced in the NAc (Rocha et al. 2002), and systemic administration of 5-HT2CR
agonists inhibited, while 5-HT2CR antagonists enhanced cocaine-induced increase of DA in the
NAc of rats (Navailles et al. 2004, Navailles et al. 2008). The behavioral effects of 5-HT2CR
agonists and antagonists have been tested quite extensively in various rat and nonhuman
primate operant models of cocaine self-administration. For example, it had been shown that
systemic administration of the 5-HT2CR agonist Ro60-0175 attenuated cocaine-induced increase
in NAc DA level in squirrel monkeys at the dose that attenuated cocaine self-administration (SA)
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and cocaine-induced reinstatement subsequent to extinction of SA (Manvich, Kimmel and
Howell 2012b, Howell and Cunningham 2015). Conversely, systemic administration of the
selective 5-HT2CR antagonist SB242084 enhanced cocaine-induced increase in NAc DA at a dose
that enhanced cocaine-induced reinstatement and maintained SA in substitution of cocaine
(Manvich et al. 2012a). In rats, studies reliably found 5-HT2CR agonists attenuate, while
antagonists enhance the behavioral effects of cocaine. Specifically, systemic administration of
5-HT2CR agonists in rodents attenuated cocaine-induced hyperlocomotion (Filip, Bubar and
Cunningham 2004), the discriminative stimulus effects of cocaine (Callahan and Cunningham
1995, Frankel and Cunningham 2004), and the direct reinforcing effects of cocaine as measured
by self-administration procedures (Fletcher et al. 2008, Cunningham et al. 2011). In addition, 5HT2CR agonists reduced reinstatement induced by cocaine and cocaine-associated cues
(Grottick, Fletcher and Higgins 2000, Neisewander and Acosta 2007, Burbassi and Cervo 2008,
Fletcher et al. 2008, Cunningham et al. 2011). Conversely, systemic administration of 5-HT2CR
antagonists induced behavioral effects that are opposite to those of agonist, enhancing
cocaine-induced hyperlocomotion (Fletcher, Grottick and Higgins 2002), the discriminative
stimulus effects of cocaine, cocaine self-administration, and cocaine-induced reinstatement
(Fletcher et al. 2002).
Previously in situ hybridization demonstrated 5-HT2CR mRNA in caudate putamen,
nucleus accumbens, amygdala, frontal and cingulate cortices, SNpc, and VTA (Pompeiano,
Palacios and Mengod 1994). Within the VTA and SNpc htr2c was detected in both dopaminergic
and GABAergic neurons (Eberle-Wang et al. 1997), while protein was found on both
dopaminergic and GABAergic neurons in the VTA (Bubar and Cunningham 2007) and in VTA
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dopaminergic neurons that project to the NAc (Bubar, Stutz and Cunningham 2011). Since
expression patterns of 5-HT2CR mRNA and protein are in general detected within the same
regions, it is likely that these receptors are predominantly postsynaptic. The localization of 5HT2CR to GABAergic interneurons of the VTA suggests that activation of these receptors inhibit
mesolimbic DA neurotransmission. Indeed, intra-VTA injection of the 5-HT2CR agonist Ro600175 attenuated the DA-increasing effects of systemically administered cocaine in anesthetized
rats (Navailles et al. 2008) and cocaine self-administration at both fixed FR5 and progressive
ratio schedules (Fletcher et al. 2004). However, the same intervention attenuated cocaine
evoked-locomotor activity (McMahon and Cunningham 2001) and operant response for food as
well. In addition, while multiple groups have shown global or systemic administration of 5HT2CR agonist and antagonist, attenuates and enhances, respectively, either drug- or cueprimed reinstatement (Fletcher et al. 2002, Fletcher et al. 2008, Pentkowski et al. 2010,
Manvich et al. 2012a, Harvey-Lewis et al. 2016), the neural substrate that may mediate these
effects remain unidentified. In sum, in spite of the localization of 5-HT2CR RNA and protein to
the VTA and demonstration of behavioral effects subsequent to exogenous manipulation, it is
unclear to what extent VTA gad1 neurons may mediate serotonin’s oppositional effect to
cocaine reinforcement. In addition, while prior findings implicated the serotonin system in
cocaine’s aversive effect (Ettenberg et al. 2011) and showed negative affective response to
cocaine predicts operant response to take and seek cocaine (Ettenberg et al. 2015), the neural
substrate that mediates cocaine-induced serotonin’s aversive effects remains unidentified.
Further, it has never been tested whether cocaine’s aversive effect may play a role in later
stages of cocaine addiction such as extinction and relapse. Thus given our previously reported
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novel finding of abundant htr2c, the gene that encodes 5-HT2CR, at the RMTg, in this
dissertation project we aimed to 1) compare and contrast the extent of htr2c expression and
htr2c+ GABAergic neuron activation following cocaine exposure in the VTA versus RMTg; 2) test
the role of RMTg 5-HT2CR function in cocaine’s aversive effects; 3) test the role of RMTg 5-HT2CR
function in individual differences in aversive response to cocaine and further stages of cocaine
addiction-like behaviors such as binging and relapse.
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Chapter 2
Methods
2.1 In Situ Hybridization and Imaging
2.1.1 Sacrifice and tissue collection
For in situ hybridization (ISH) using the RNAscope kit, animals were deeply anesthetized via
inhaled isoflurane and perfused transcardially with 0.9% NaCl (55 ml/min for four minutes) and
10% neutral-buffered formalin (for a total volume of 150-200 ml, adjusted based on body
weight, 55 ml/min for one minute then 30 ml/min). Brains were removed, post-fixed overnight
at 4 °C, and transferred to 15% sucrose in phosphate buffered saline for 24 hours prior to
freezing and sectioning.
2.1.2 Multiplex Fluorescent in situ hybridization (RNAscope)
mRNA was visualized using methods previously described (Smith et al. 2019). In brief, frozen
unfixed tissue was cut on a cryostat into 14 µm sections and mounted onto SuperFrost Plus
slides. Slides were than stored at -80 °C. To quench endogenous peroxidases and digest nucleic
acid-associated proteins, slides were treated with 3% hydrogen peroxide, ACD Target Retrieval
Reagent (cat# 322000), and ACD Protease III reagent (cat# 322340). To detect rat mRNA,
sections were hybridized with RNAscope probes specific for th (cat# 314651), gad1 (cat#
316401), foxp1 (cat# 485221), htr2c (cat# 469321), neun (cat# 436351), and fos (cat# 403591)
using the HybEZ Hybridization System (cat# 310010) for two hours at 40 °C. The hybridization
was amplified and detected using RNAscope Multiplex Fluorescent Detection Kit v2 (cat#
323110) for multiplex fluorescent stain. TSA fluorophores fluorescein (cat# NEL741001KT), TSA
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cyanine 3 (cat# NEL744001KT), and TSA cyanine 5 (cat# NEL 745001KT) were purchased from
Akoya Biosciences (Marlborough, MA, USA).
2.1.3 Image Acquisition and Analysis
Imaging of fluorescent RNA ISH signals was performed using Canon EOS Rebel T3 camera
mounted on an Olympus BX40 microscope at 10x or 20x magnification, thereafter a pipeline of
CellProfiler image and object processing modules were used for cell segmentation and FISH
signal quantitation (Carpenter et al. 2006). Briefly, nuclear segmentation and contour detection
were optimized using DAPI counterstain based on features nuclear size, nuclear intensity, and
nuclear contrast from the background. Probe detection was optimized based on signal size,
intensity of positive probe pixels and contrast threshold. Probe signals were recorded both as
number of individual puncta as well as total signal area and integrated fluorescent intensity (the
sum of the pixel intensities within an object) per cell on a continuous scale. For absolute
quantification of probe signals, physically separated punctum was counted as one probe copy.
Thresholding for the single copy intensity (the intensity of one putative RNA signal/punctum)
was performed using individual probe signals in positive cells. A spot was classified as a cluster
when its intensity surpassed the single copy intensity threshold. The probe count of each
cluster is derived from integrated intensity divided by the single copy intensity. Probe signals
were assigned to each nucleus by proximity within a maximum of cell radius of 30 pixels.
Positivity threshold for each gene of interest or probe, in terms of the number of puncta or
copies, was determined depending on probe signal strength and each gene or probe’s proclivity
for exhibiting background, i.e., the presence of RNA signals that could not be related to any
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parental or nuclei object. For our present analysis, we used a minimum of 5 copies for neun, 3
copies for foxp1, 1 copy for htr2c and gad1, and 5 copies for fos.

2.2 Animals and Surgeries
2.2.1 Animals
Adult male Sprague Dawley rats (Charles River Laboratories, Raleigh, NC, and Envigo,
Indianapolis, IN, USA), weighing 320-350 upon delivery from vendor, were individually housed
in standard ventilated cages within a temperature-control (20 °C), 12/12 h light/dark cycle
(lights on at 6:00 am) vivarium, with food and water provided ad libitum, unless otherwise
stated. Procedures conformed to the National Institute of Health Guide for the Care and Use of
Laboratory Animals, and all protocols were approved by Medical University of South Carolina
Institutional Animal Care and Use Committee. All animals were tested during the light phase.
2.2.2 Catheter Surgeries
Rats were anesthetized with isoflurane and fitted with indwelling intravenous catheters
inserted into the right jugular or right femoral vein, and subcutaneously passed to a guided
cannula exiting the animal’s back. After surgery, catheter patency was maintained via daily
flushing with 0.05 ml of Taurolidine Citrate Solution. Animals were allowed seven days of
recovery prior to behavioral testing. Catheter patency was assessed periodically through
observation of loss of the righting reflex after intravenous injection of methohexital (Brevital,
2.0 mg/kg/0.1ml). Rats that were unresponsive to Brevital were implanted with a new catheter
using the left jugular or femoral vein.
2.2.3 Stereotaxic Surgeries
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Stereotaxic intracranial cannula implantation or viral vector injections were performed in rats
anesthetized with isoflurane (1-3% in 95% O2 5% CO2 provided via nose cone at 1L/min).
Following anesthesia, sterilization of the scalp, and exposure of the skull surface, craniotomy
holes were drilled over the RMTg (anterior-posterior 6.90-7.25 mm, dorsal-ventral 6.15-7.35
mm, medial-lateral 2.00 mm, relative to Bregma, from dura), IPN (AP –7.00 mm, DV –7.8 mm,
ML 1.1 mm), or VTA (AP –4.90 mm, DV –7.7 mm, ML 2.0 mm). Guided cannula that were 11 mm
long and 26 gauge (cat no. C315G, P1 technologies, Roanoke, VA) were angled at 10 degrees,
inserted and lowered to the corresponding structures. For delivery of AAV viral vectors
encoding scrambled or htr2c shRNA, injections were made using a pulled glass micropipette
and nanoject II injector (Drummond Scientific Co., Broomall, PA). A total volume of 150-200 nL
was delivered for each nucleus at 32 nL incremental boluses that were spaced 30 seconds
apart. In the case of cannula implantation, cannula were affixed to skull with dental cement.
Animals were given subcutaneous injections of ketoprofen (5 mg/kg) and prophylactic
antibiotic cefazolin (10 mg/kg) after surgery and allowed to recover for seven days before any
behavior testing.

2.3 Behaviors
2.3.1 Drug dose and microinfusion
5-HT2CR antagonist SB242084 and agonist Ro60-0175 were obtained from Tocris Bioscience.
Compounds were dissolved in 8% beta-cyclodextrin 0.9% saline solution. SB242084 was used at
0.5 µg/0.2 µL per side of the RMTg nuclei (McMahon and Cunningham 2001), and Ro60-0175
was used at 5 µg/0.25 µL per side (Fletcher et al. 2004). Compound or vehicle was infused at a
controlled rate of 0.2 µL/30 seconds. After microinfusion, injector was left in place for one
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minute to prevent backflow and encourage absorption of compound by brain tissue. Previous
data from our lab showed insertion of microinjector to the RMTg alone exerts a measurable,
albeit statistically insignificant, impact on runway and elevated plus maze experiments, possibly
due to mechanical irritation of the RMTg structure that results in function disruption. Hence, to
minimize this potentially confounding effect, compound or vehicle solution was microinfused to
bilateral RMTg 20 minutes to an hour before any behavior testing.
2.3.2 Runway operant cocaine-seeking
Methods are similar to our previous work (Jhou et al. 2013). Briefly, the runway consists of two
opaque plastic compartments referred to as “start box” and “goal box” (25x10x17 cm
length/width/height) connected by a 170 cm long corridor with motorized doors between the
start and goal boxes and corridor. Rats were tethered to an intravenous line, then placed into
the start box, after which doors were opened to allow free exploration of the apparatus. Entry
into the goal box caused doors to close and a syringe pump to deliver cocaine (0.75 mg/kg iv,
same dose as in CPP/CPA). Failure to enter the goal compartment after 15 minutes resulted in a
“timeout”. During the light cycle over a period of four to five days, seven trials were given, at
most twice daily and at least four hours apart, to ensure that animals were tested in a cocainefree state. All animals were habituated to the runway apparatus before starting cocaine trials;
all animals must have at least 2 consecutive habituation sessions with run latency less than 60
seconds before progressing to the first cocaine session. Criterion for a retreat was a reversal in
direction for a distance spanning a minimum of two photobeams. To test the effect of 5-HT2CR
antagonist SB242084 on runway latency, compound or vehicle was microinfused to bilateral
RMTg 20 minutes before the start of runway.
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2.3.3 Conditioned Place Preference/Conditioned Place Aversion (CPP/CPA)
A 3-chamber apparatus with two conditioning chambers (having dark versus light colored walls)
and a smaller neutral center chamber was used. Prior to any conditioning, animals were
subjected to habituation and free exploration of the CPP/CPA apparatus for a total of three
sessions, 15 minutes each. An animal’s three-session average time spent in each chamber was
taken to be its baseline preference. After the baseline preference was established, each animal
was randomly assigned to either the light or dark chamber to be its drug-paired side and
received a total of eight conditioning sessions (four with microinfused pharmacological
compound or vehicle and intravenous cocaine in the drug-paired chamber, and the other four
with microinfused vehicle and intravenous saline in the opposite chamber). To test the effect of
5-HT2CR agonist Ro60-0175 on place preference, compound or vehicle was microinfused to
bilateral RMTg 20 minutes before each conditioning session. To test the effect of 5-HT2CR
antagonist on the rewarding effect of cocaine, compound or vehicle was microinfused to
bilateral RMTg an hour prior, and a single infusion of intravenous cocaine (075 mg/kg) was
given right before conditioning. To test the effect of 5-HT2CR antagonist on the aversive effect
of cocaine, compound or vehicle was microinfused to bilateral RMTg an hour prior, and a single
infusion of intravenous cocaine (0.75 mg/kg) was given 15 minutes before conditioning.
Animals were placed into the conditioning chambers for 15 minutes after receiving intra-RMTg
vehicle and IV saline injections during morning sessions, and again after receiving intra-RMTg
vehicle or compound and IV cocaine injections during afternoon sessions. After all conditioning
sessions were completed, place preference was tested once and recorded for 15 minutes for
each animal subject without any drug or compound treatment. The post-test preference score
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for the drug paired-chamber is defined as the difference between an animal’s pre- and postconditioning time spent expressed as a percentage over the animal’s pre-conditioning time
spent in the drug paired-chamber.
2.3.4 Novelty-Induced Locomotion
Novelty-induced locomotion was recorded in operant chambers placed inside soundattenuating cabinets. In a span of 30 minutes, movements within the chamber were detected
via interruptions of an array of four photodetector/emitter pair and recorded. In experiments
involving cocaine, animals were given intraperitoneal injection of cocaine (10 mg/kg), placed
into the operant chambers immediately, and then movements were recorded for 30 minutes.
2.3.5 Progressive ratio and Punishment Resistance
Training procedures are identical to those we previously described (Vento 2017). Animals are
food restricted to 85% of initial body weight, trained to leverpress for food pellets (45 mg
vanilla pellet) until stable response rates were reached, then tested either on the progressive
ratio (PR) task with progressively increasing effort requirements (leverpresses required per
pellet) (Richardson and Roberts, 1996), or progressively increasing punishment (i.e. a footshock
of increasing intensity presented 1 second after food pellet delivery, whose magnitude
increases 25% every three trials). In the progressive ratio task, rats time out if two minutes
passed without a leverpress. In the shock task, a timeout is defined by three consecutive trials
with more than 30 seconds passing without a leverpress. For both tasks, the breakpoint is the
last successfully completed ratio or shock intensity endured before timeout.
2.3.6 Self-Administration
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After being tested on the runway task and AAV viral vector injection, animals were trained on a
daily two-hour session of cocaine self-administration during the light cycle, in standard Med
Associates operant chambers equipped with two levers, a house light, cue light, and tone
generator. The designated active lever delivered an infusion of cocaine (0.75 mg/kg/infusion)
dissolved in sterile 0.9% saline, along with a compound cue (light and tone) on an FR1 schedule
of reinforcement. Following each infusion, a 20 seconds time out was signaled by the loss of
illumination of the house light during which active lever presses resulted in no programmed
consequence. In the same time period, responses on the inactive lever were recorded but
produced no program consequence either. Self-administration training was conducted once
daily. During self-administration training, for rats that did not spontaneously acquire leverpressing within the first three sessions, the active lever was baited with a chow food pellet.
Once rats reached stability, defined as ten or more infusions per session, food baiting was
removed. After a minimum of ten days of self-administration of more than ten infusions,
animals that achieved discrimination between inactive and active levers (>50% active lever
presses out of total lever presses) and consistent number of infusions (last three sessions in
which the number of infusions received did not vary by more than 20% compared to the
previous session) were subjected to extinction training. During extinction, rats were exposed to
the SA environment for a two-hour session each day for ten consecutive days. During the
extinction sessions, lever presses had no program consequences, i.e., no longer produced drug
or presentation of drug-paired cues. Rats received extinction training on a minimum of seven to
eight consecutive days until the responding on the active lever fell to less than 20% of the
active lever pressing during the last three days of self-administration for three consecutive
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days. The day after achieving this criterion, subjects were returned to the operant chambers for
reinstatement testing. For cue reinstatement, active lever presses resulted in the presentation
of the cues (both light and tone) but no cocaine infusions.
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Chapter 3
Genetic Characterization and Response to Cocaine of
VTA and RMTg GABAergic neurons
3.1 Introduction
3.1.1 GABAergic Neurons of the VTA
The ventral tegmental area (VTA) dopamine neurons have been implicated in diverse
processes including positive and negative reinforcement, decision making, working memory,
incentive salience, stimulus salience, and aversion (Adcock et al. 2006, Berridge 2007, Brischoux
et al. 2009, Bromberg-Martin, Matsumoto and Hikosaka 2010, Salamone and Correa 2012,
Schultz 2002). Such behavioral heterogeneity may be related to the diverse phenotypic and
genetic characteristics of VTA dopamine neurons and the brain structures they innervate. The
activity of VTA dopamine neurons is regulated by inputs from diverse brain regions, as well as
by resident GABA-releasing neurons, which comprises about 30% of all VTA neurons (Dobi et al.
2010). In addition to providing local control, they also send long-range innervation to many
brain structures that are innervated by VTA dopamine neurons such as the nucleus accumbens
(Xia et al. 2011). GAD-expressing neurons have been found to be distributed throughout the rat
VTA (Margolis et al. 2012, Olson and Nestler 2007). In vivo recordings in mice have shown that
VTA GABA neurons respond to aversive stimuli (Cohen et al. 2012), as a population increases
their firing rate upon exposure to reward predictive cues, and they exhibit sustained
enhancement of firing rate during the “waiting” period between cue and reward receipt. In
agreement with a possible role of VTA GABA neurons in aversion, the activation of some
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populations of VTA GABA neurons has been shown to inhibit DA neurons of the VTA (Tan et al.
2012), confer place aversion and antagonize appetitive behaviors such as reward consumption
(Stamatakis et al. 2013, Tan et al. 2012, van Zessen et al. 2012).
3.1.2 RMTg, a Predominantly GABAergic Structure
The rostromedial tegmental nucleus (RMTg), sometimes referred to as the tail of VTA
(tVTA), is a GABAergic nucleus first described as a major inhibitory input to neurons in the VTA
(Perrotti et al. 2005, Jhou et al. 2009a, Kaufling et al. 2009). RMTg afferents make dense
inhibitory-type synapse on tyrosine hydroxylase (TH)-positive neurons in the VTA and
substantia nigra (SNc) (Jhou et al. 2009a), in addition to abundant local projections to brainstem
regions important for the control of motivation, stress, attention, and arousal such as the dorsal
raphe, pedunculopontine tegmental nucleus, locus coeruleus and subcoeruleus (Jhou et al.
2009a, Lavezzi, Parsley and Zahm 2012, Sego et al. 2014). Efferents from the RMTg to DA
neurons of the VTA and SNc show a topographical organization with the rostro-medial RMTg
sending denser projection to the VTA while the latero-caudal RMTg to the SNc. The RMTg
receives dense excitatory glutamatergic inputs from the lateral habenula (LHb), which has been
identified and established as a major source of negative reward signal (Matsumoto and
Hikosaka 2008, Hikosaka 2010, Proulx, Hikosaka and Malinow 2014), and the density of LHb
projection to the RMTg exceeds that to the VTA (Brinschwitz et al. 2010, Balcita-Pedicino et al.
2011). Tracing studies show projections from the LHb to the RMTg follows a topographical
organization as well, with the medial LHb regions projecting to the medial and rostral part of
the RMTg, and the lateral LHb projecting to the more lateral and caudal parts of the RMTg (Jhou
et al. 2009a). Thus, the RMTg acts to convert the excitatory LHb glutamatergic input to
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inhibitory GABAergic output to the midbrain DA neurons. Other strong inputs to the RMTg
include structures implicated in aversive responses such as the anterior cingulate cortex (Vogt
2005), septum (Sheehan, Chambers and Russell 2004), parts of the extended amygdala (2010
Davis), and the periaqueductal gray (McNally, Johansen and Blair 2011).
Previously it has been established that the RMTg structure is comprised of a
heterogenous population of small and medium-sized neurons that are largely (70-92%)
GABAergic (Jhou et al. 2009a, Kaufling et al. 2009) and respond with Fos expression following
exposure to aversive stimuli and psychostimulants (Jhou et al. 2009a, Perrotti et al. 2005,
Kaufling et al. 2009, Kaufling et al. 2010). A genetic marker, the transcription factor Foxp1, has
recently been described and characterized both in mice and rats (Lahti et al. 2016, Smith et al.
2019), and shown to be selectively expressed in the RMTg relative to adjacent areas such as the
VTA. Electron micrographic analysis found almost all RMTg axons contacting the VTA are
unmyelinated and mostly comprised of small-diameter intervaricose segments or vesiclecontaining boutons that do not contact surrounding dendrites, with the remaining being
unmyelinated axons having varicosities that are in direct contact with surrounding dendrites
forming either synaptic connections or membrane appositions (Balcita-Pedicino et al. 2011). In
vivo, the mean firing rate of RMTg neurons is between 11 and 18 Hz, while in vitro RMTg
neurons fire at 5 Hz (Jalabert et al. 2011, Lecca et al. 2006).
It has been suggested that the RMTg plays an important role in conveying information
about aversive stimuli to VTA and SNc DA neurons and mediating inhibitory behavior in
response to these stimuli (Hong et al. 2011, Jhou et al. 2009a, Jhou et al. 2013, Vento et al.
2017, Brown et al. 2017). RMTg neurons are inhibited by rewards and reward predictive cues,
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and activated by aversive stimuli and punishment predictive cues, and unexpected omission of
reward (Li et al. 2019), in a manner that is diametrically opposite to that of VTA DA neurons but
similar to glutamatergic neurons’ of the LHb (Matsumoto and Hikosaka 2007, Cohen et al.
2012). Evidence strongly suggests that the RMTg plays a critical role in aversive processing and
inhibitory behavior control via its inhibitory projections to VTA and SNc DA neurons. Our lab
and others have shown RMTg neurons are activated by a range of aversive stimuli of varying
sensory modalities and timescales, including footshock, loud siren, bright light, lithium chloride,
restraint stress, and cocaine (2019a Li). It was shown RMTg drove VTA inhibitions (BalcitaPedicino et al. 2011, Bourdy et al. 2014) and conditioned place aversion (CPA) to these aversive
stimuli, without affecting VTA activation or CPP to rewarding stimuli (Li et al. 2019). The RMTg
has also been implicated in the regulation of motor activity as ablation of the RMTg results in
release of DA in the dorsal striatum and motor enhancement (Bourdy et al. 2014). Combining
the RMTg’s roles in affective encoding of aversive stimuli and inhibitory control of locomotor or
motor functions, the RMTg has been shown to play an important role in passive avoidance and
avoidant behavior in response to aversive and fear-provoking stimuli. Lesion of the RMTg was
shown to decrease open arm avoidance on the elevated plus maze (Jhou et al. 2009a).
Activation or inhibition of the RMTg to VTA pathway produces conditioned place avoidance and
preference, respectively (Smith et al. 2019). Furthermore, lesion or inactivation of RMTg
neurons have been found to reduce many aversive and inhibitory behaviors including
conditioned place avoidance, fear-induced freezing, nociceptive response, punishment
resistance, and acute and chronic withdrawal from drugs of abuse (Jhou et al. 2009a, Jhou et al.
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2013, Smith et al. 2019, Vento et al. 2017, Glover et al. 2019, Greco et al. 2008, Elmer et al.
2019, Kaufling and Aston-Jones 2015).
3.1.3 Functional and Molecular Genetics Distinctions Between RMTg and VTA GABAergic
Neurons
Previously both RMTg and VTA GABAergic neurons have been shown to exert similar
inhibitory influences on DA neurons in encoding reward prediction errors (Hong et al. 2011,
Jhou et al. 2009a, Stopper et al. 2014, Eshel et al. 2015), and that activation of either RMTg or
VTA GABAergic neurons induce behavioral avoidance (Jhou et al. 2009a, Jhou et al. 2009b,
Lammel et al. 2012, Tan et al. 2012, Stamatakis et al. 2013). However, these two populations of
GABAergic neurons of the midbrain have been found to be distinctive in the following ways.
First, RMTg neurons are more responsive to mu opioid receptor agonists than VTA neurons are.
mu opioid agonists are more reinforcing when injected into the RMTg than the VTA, and mu
opioid agonists block inhibition of DA neurons induced by stimulation of the RMTg but not that
induced by activation of VTA GABAergic interneurons (Jalabert et al. 2011, Matsui and Williams
2011, Jhou et al. 2012, Matsui et al. 2014, Zangen et al. 2002). Second, it was found that
GABAergic neurons in the VTA showed ramping activities in response to reward cues and
remained activated until subjects receive rewards, which was construed to encode or correlate
with expectation (Cohen et al. 2012, Eshel et al. 2015), while the same response has not been
identified at the RMTg and RMTg neurons are more associated with or characterized by phasic
inhibition by reward cues. Third, VTA, but not RMTg, GABAergic neurons appear to modulate
DA phasic response to reward. Optogenetic inhibition of VTA GABA interneurons disrupts
phasic DA response to reward cues and results in sustained DA activation throughout the entire
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presentation of cues (Eshel et al. 2015), whereas RMTg lesions removed most of VTA inhibition
following aversive stimuli or cues but had no impact on DA response to reward cues (Li et al.
2019). Fourth, RMTg GABAergic neurons are enriched in Pnoc and Foxp1, while the number of
cells positive for those markers are much lower in the VTA (Smith et al. 2019).
Previously 5-HT2CR expression has been demonstrated and described on both GABAergic
and TH neurons of the VTA (Bubar and Cunningham 2007, Bubar et al. 2011). While several
studies have implicated the role of 5-HT2CRs positive GABAergic neurons of the VTA in opposing
cocaine’s reinforcing effects (McMahon, Filip and Cunningham 2001, Fletcher et al. 2004,
Navailles et al. 2008), it has not been assessed and it is unclear to what extent these neurons
are activated endogenously following exposure to cocaine. Aim 1 seeks to better characterize
and compare the expression and extent of co-localization of foxp1, gad1, and htr2c at the RMTg
and VTA, and characterize and compare the extent of cfos expression following cocaine
exposure in htr2c GABAergic neurons of the RMTg and VTA.

3.2 Results
3.2.1 RMTg Neurons Express Abundant htr2c
Our prior RNAseq study of RMTg neurons showed high expression of htr2c (Smith 2019).
New analyses of our RNAseq data found that in RMTg, htr2c is not only highly expressed, but
exceeds expression of all other dopamine, adrenergic, and serotonin receptors detected by a
large margin, with an average RPKM value of 40.2, followed by htr2a (8.5), drd2 (7.1), and htr7
(3.62). All other receptors are expressed at negligible levels (< 1 RPKM) (Figure 3.1C). Using
multiplex fluorescent in situ hybridization (FISH), we first replicated and extended earlier
findings that the RMTg is characterized by enriched gad1 and foxp1. In the previously
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established RMTg region dorsolateral to the midline structure interpeduncular nucleus (IPN)
(Figure 3.1A-B), we found in 1774 cells (enumerated from seven sections of three rats) that are
positive for neun, a neuronal marker, 91% and 86% were gad1 and foxp1 positive, respectively,
and more than 75% are gad1 and foxp1 double positive (Figure 3.1D-H). We next showed that
in the RMTg htr2c mRNA is highly colocalized with neun, gad1 and foxp1. Double-label FISH for
htr2c and neun revealed in 1972 htr2c cells (enumerated from nine sections of four rats), 98%
express neun, and conversely 80% of 1968 neun cells (enumerated from nine sections of four
rats) express htr2c (Figure 3.1I-L), indicating almost all htr2c cells are neuronal, and a large
majority of RMTg neurons are positive for htr2c. Triple label-FISH for htr2c, foxp1, and gad1
showed at multiple anterior-posterior (AP) levels of the structure, the percentages of gad1 and
foxp1 positivity in htr2c cells are consistently high (Figure 3.2P). In 1204 RMTg htr2c neurons
enumerated (from nine sections of three rats), we found 94% are gad1 positive, 85% are foxp1
positive, and 82% are gad1 and foxp1 double positive (Figure 3.2Q). In summary, via examining
gad1 positive and htr2c positive neurons, which account for almost all neurons at the RMTg,
Figure 3.2R illustrates three predominant RMTg neuron subtypes may be distinguished based
on differential expressions of htr2c, foxp1, and gad1. A large majority out of 2388 htr2c and
gad1 positive cells (enumerated from 14 sections of four animals) were positive for all three
genes (htr2c, foxp1, and gad1), and the remaining two types are characterized by htr2c
negativity and zero to low percentage of foxp1 expression. These results suggest a large portion
of RMTg neurons may be regulated by serotonin via 5-HT2CRs, but the functional significance of
this remains to be determined.
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3.2.2 VTA GABAergic Neurons are Genetically and Functionally Different from Those of the
RMTg
Using multiplex FISH to examine gene RNA expression at the VTA, we largely replicated
and elaborated upon previous findings that demonstrated 5-HT2CR expression on GAD67
neurons of the VTA (Bubar and Cunningham 2007, Bubar et al. 2011). As shown in Figure 3.3AE, when various anterior-posterior levels (relative to bregma, -4.80 to -5.64 mm) of the VTA was
examined in terms of the expression of th, htr2c, and gad1 RNA, it can be appreciated that
there is a medial and lateral division of cell identity in terms of the expression of these three
markers. Specifically, midline nuclei including rostral linear raphe nucleus (RLi), interfascicular
nucleus (IF), and interpeduncular nucleus (IP), and the medial division of parabrachial
pigmented nucleus (PBP) and paranigral nucleus (PN) are more enriched for presumed
glutamatergic neurons that are th negative and htr2c positive, while lateral division of the PBP
and PN are more enriched for DA neurons that are strong in th expression but negative for
htr2c, and a high percentage of gad1 neurons that are htr2c positive. These observations can
also be appreciated in magnified Figure 3.3Ca’-Ca’’’’, which illustrate presumed glutamatergic
neurons that are th negative but positive for htr2c are located more medially, while DA neurons
that are strong in th but negative for htr2c are located more laterally, and gad1 positive cells, a
large proportion of which is htr2c positive, in general are much more concentrated in PBP and
PN nuclei of the VTA.
The current study also replicated and elaborated upon previous findings that reported
the RMTg has a significantly higher number of Foxp1 positive neurons than the VTA (Smith et al.
2019). Specifically, as illustrated in Figure 3.4A-I and summarized in Figure 3.4J, when individual
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gad1 neurons of the RMTg and VTA are plotted as a function of gad1, htr2c, and foxp1 density,
it is evident that individual RMTg gad1 neurons show higher density of foxp1 than gad1
neurons of the VTA. In addition, Figure 3.4K-M show in individual gad1 neurons, foxp1 and
gad1 density are significantly higher while htr2c density is significantly lower at the RMTg
compared to the VTA.
Previously both VTA and RMTg GABAergic neurons have been shown to respond to
aversive stimuli (Cohen et al. 2012, Jhou et al. 2009a), however, while numerous reports have
demonstrated strong cFos expression at the RMTg following exposure to psychostimulants
(Geisler et al. 2008, Jhou et al. 2013, Sanchez-Catalan et al. 2017), cFos response at GABAergic
neurons of the VTA following cocaine exposure has not been examined. In this report using
multiplex FISH which enables the examination of cfos response to cocaine in a cell-type specific
manner, we found that following cocaine exposure, in htr2c cells, the RMTg shows a
significantly higher proportion (42.63 ± 4.38%, 10 rats) of cfos positivity compared to the VTA
(20.38 ± 3.15%, 6 rats) and the IPN (5.482 ± 1.52%, 6 rats) (one-way ANOVA, F(2,19) = 24.85, p <
0.0001; Tukey’s post hoc test, VTA vs. RMTg, p = 0.0017; RMTg vs. IPN, p < 0.0001) (Figure
3.5M). Furthermore, when cocaine cfos density of individual htr2c neurons are compared, as a
distribution the expression of cfos at the RMTg is significantly higher than those at the VTA and
IPN (Kruskal-Wallis ANOVA, p < 0.0001; Dunn’s post hoc test, VTA vs. RMTg, p < 0.0001; RMTg
vs. IPN, p < 0.0001) (Figure 3.5N). Finally, we found that similar to the RMTg, there’s a
significant proportion of htr2c neurons at the VTA that are gad1 positive, and in contrast to the
RMTg where almost all htr2c are gad1 thus making the percentage of cfos positivity in htr2c and
gad1 double positive cells close to 40% as well, at the VTA the percentage of cfos positivity in
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gad1 and htr2c double positive cells is comparatively less at 22% (n=2, 14%-30%) (Figure 3.6 AB).

3.3 Discussion
The present findings corroborate the RMTg is a primarily GABAergic structure that is
characterized by rich foxp1 expression. Previously it has been shown that the RMTg has
significantly higher number of Foxp1 positive neurons than the VTA (Smith 2019). However, it
was not clear whether that was due to in absolute numbers the VTA having less GABAergic
neurons than the RMTg, or whether the VTA might have a lower percentage of Foxp1 positivity
in GAD1 cells. In the current study taking advantage of the ability of multiplex FISH to enable
examining and quantifying foxp1 density in gad1 positive cells, the present findings addressed
this question directly by showing the VTA has a lower percentage of fox1 positivity in gad1 cells,
and in terms of all individual neurons, RMTg gad1 neurons express higher level of foxp1 density
than those of the VTA. In addition, our present findings corroborated GABAergic neurons at the
VTA and RMTg, despite sharing the common characteristic of gad1 expression, are more likely
to be genetically different since they have significantly different levels of htr2c as well. It
remains to be further investigated exactly what might be the function of foxp1 expression in
both VTA and RMTg gad1 neurons, and how may VTA and RMTg GABAergic neurons may be
functionally similar and different.
The present findings made the novel discovery of enriched htr2c expression on bona
fide RMTg neurons that are characterized by largely co-localized expression of foxp1 and gad1.
Previously the serotonin system and 5HT2CR function have been implicated in opposing the
reinforcing effects of cocaine and avoidance response to cocaine (Carroll et al. 1990b, Roberts
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et al. 1994, Fletcher et al. 2002, Fletcher et al. 2008, Cunningham et al. 2011, Gerak, Collins and
France 2016, Harvey-Lewis et al. 2016, Manvich et al. 2012a, Ruedi-Bettschen, Spealman and
Platt 2015, Ettenberg et al. 2015). However, the neural substrate that mediates serotonin’s and
5HT2CR’s roles in cocaine’s aversive property has not been identified. Withstanding a prior
account that attributed the effects of 5-HT2CR function on operant response for cocaine to 5HT2CR positive GABAergic neurons of the VTA (Fletcher et al. 2004, Bubar and Cunningham
2007, Bubar et al. 2011), it has never been examined and demonstrated that GABAergic
neurons of the VTA activate in response to or following cocaine exposure. The present findings
showed that gad1 neurons at the VTA are activated, as indicated by the percentage and density
of cfos expression, following cocaine exposure to a lesser extent than gad1 neurons at the
RMTg, and that 5-HT2CR function at the RMTg may be further tested for a role in serotonin’s
and cocaine’s aversive and inhibitory properties.
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Figure 3.1. The rat RMTg expresses abundant htr2c, gad1, and foxp1. A. The RMTg appears at the rat ventral
midbrain as two bilateral egg-shaped nuclei that are dorsomedial to the midline interpeduncular nucleus
(IPN). B. In such region the expression of a transcription factor, foxp1 (in red), is enriched relative to
immediately adjacent area. C. In such area, RNAseq identified the expression of genes that encode various
dopaminergic, adrenergic, and serotonergic receptor subtypes, amongst which the gene, htr2c, that encodes
the 5-HT2CR shows the highest expression level (average RPKM 40.22 of n=3, indicated by green shaded
column). D-H. A majority of RMTg neurons, cells positive for neun, express gad1 (n=3, gad1/neun 88-90%,
mean ± SEM 89 ± 0.7%) and foxp1 (n=3, foxp1/neun 84-85%, mean ± SEM 85 ± 0.1%). I-L. Virtually all htr2c
positive cells at the RMTg is neuronal as indicated by neun expression (n=4, neun/htr2c 94-99%, mean ± SEM
97 ± 1%), and a majority of neun cells at the RMTg express htr2c (n=4, htr2c/neun 72-91%, mean ± SEM 81 ±
3.9%). Scale bar = 250 µm.
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Figure 3.2. At various anterior-posterior (AP) coordinates, the RMTg structure may be distinguished from
the adjacent IPN by the consistent high degree of co-expression of htr2c, foxp1, and gad1. A-O. At the RMTg,
most neurons exhibit a high degree of triple expression of htr2c, foxp1, and gad1, whereas the IPN is
populated by subnuclei that may be distinguished from each other by the differential co-expression of two,
but not all three of these genes. P-Q. Throughout the RMTg, RMTg htr2c neurons are consistently GABAergic
(n=3, gad1/htr2c, 89-98%, mean ± SEM 94 ± 2.5%) and foxp1 positive (n=3, foxp1/htr2c, 84-85%, mean ± SEM
84 ± 0.4%). Scale bar = 250 µm. R-Sb’’’’. The RMTg structure may be largely accounted for by three subtypes of
neurons based on the genes htr2c, gad1, and foxp1. A large majority is characterized by the triple expression
of these three genes (cells indicated by full arrows). Two other subtypes are characterized by htr2c negativity
(cells indicated by arrowheads) and foxp1 negativity (cells indicated by empty arrowheads). A majority of
RMTg GABAergic neurons are htr2c positive (n=4, htr2c/gad1, 74-91%, mean ± SEM 83 ± 3.6%). Scale bar = 100
µm.
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Figure 3.3. (A-Ca’’’’) At the VTA gad1 neurons are mostly found in lateral subnuclei such as
PBP and PN but not midline subnuclei such as RLi, IF, and IN. At more medial locality of the
PBP and PN, htr2c neurons are gad1 negative, while at the more lateral locations of PBP and PN
htr2c neurons are gad1 positive. Scale bar = 250 µm. While solid arrows indicate gad1 and htr2c
double positive neurons. Empty arrow heads indicate htr2c positive but gad1 negative cells.
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Figure 3.4. gad1 neurons of the VTA are genetically different from those of the RMTg. A-H. Representative
images of gad1, htr2c, and foxp1 expression at the VTA and RMTg. I. Of htr2c and gad1 positive neurons of the
VTA, a relatively minor proportion of them is foxp1 positive. J-M. Of individual gad1 neurons, those at the
RMTg express higher level of foxp1 density than those at the VTA. Scale bar = 250 µm. K. Mann Whitney test,
**** p<0.0001. L. Mann Whitney test, *p=0.0339. M. Mann Whitney test, ****p<0.0001.
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Figure 3.5. Compared to both the VTA and IPN, cfos response to cocaine in htr2c neurons at the RMTg is
more numerous and of higher density. A-Lb’’’’. Representative images of cfos expression in htr2c neurons of
the RMTg, VTA, and IPN. A-L: scale bar = 250 µm. M-Lb’’’’: scale bar = 100 µm. M. The percentage of cfos
positive htr2c neurons is higher at the RMTg than at both the VTA and the IPN. **p=0.0017, ****p<0.0001,
Tukey’s multiple comparisons test. N. At the RMTg, cfos density in individual htr2c neurons is also collectively
higher than that in individual htr2c neurons of the VTA and IPN. ****p<0.0001, Dunn’s multiple comparisons
test. VTA (238 cells/4 rats), RMTg (778 cells/9 rats), IPN (81 cells/6 rats). Orange bars indicate means. White
solid arrows indicate htr2c neurons that are cfos positive.
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Figure 3.6. cfos expression following cocaine exposure in htr2c and gad1 double positive
neurons at the VTA. A. Representative image of cfos expression following cocaine exposure at
the VTA. Full arrows indicate cfos expression in htr2c and gad1 double positive neurons.
Arrowheads indicate cfos expression in htr2c positive neurons. Empty arrowheads indicate cfos
expression in htr2c and gad1 negative neurons. Scale bar = 250 µm. B. *22% of htr2c and gad1
double positive neurons at the VTA express cfos following cocaine exposure.
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Chapter 4
Electrophysiological and Behavioral Studies of 5-HT2CR
Function at the RMTg
4.1 Introduction
4.1.1 Precedent Electrophysiological Evidence and Characterization of 5-HT2CR Function
There are a total of seven classes of 5-HTXRs which are classified based on sequence
homology and functional differentiation. Like all other G protein couple receptors (GPCRs), 5HT2CR is composed of seven transmembrane spanning helices (TM I – VII), three extracellular
(ECL 1-3) and three intracellular loops (ICL 1-3), an intracellular carboxy-terminus, and an
extracellular amino-terminus (Peng et al. 2018). While the ECL and ICL sequences are known to
vary across receptor subtypes, the TM region which forms the orthosteric binding site for
serotonin 5-HT displays approximately 80% sequence homology across receptor subtype family
members (Heifetz et al. 2016). The canonical 5-HT2CR signaling downstream of stimulation by
ligand involves Gaq/11 activation of the enzyme phospholipase Cb (PLCb), which mediates the
hydrolysis of phosphatidylinositol 4,5-biphosphate (PIPs) to generate the intracellular second
messenger inositol-1,4,5-triphosphate (IP3) and result in the accumulation of the downstream
IP3 metabolite inositol monophosphate (IP1) and diacylglycerol (DAG).The extent to which 5HT2CR is activated is often measured by the level of IP1 and intracellular Ca2+ (Seitz et al. 2012).
In addition to the canonical signaling cascade involving Gaq/11, 5-HT2CR has also been shown to
transduce signaling via Ga12/13 to activate PLA2, which hydrolyzes arachidonic acid-containing
phospholipids to produce free arachidonic acid (Burke and Dennis 2009), and protein kinase C
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(PKC) to result in the phosphorylation of ERK1/2 (Werry et al. 2005, Werry et al. 2008). The
functionality of 5-HT2CRs has been shown to be regulated by RNA editing (O'Neil and Emeson
2012), formation of homo- or heterodimers (Herrick-Davis et al. 2015), and association with
beta-arrestins, which are known to play a key role in desensitization and receptor
internalization into endosomes (Marion, Weiner and Caron 2004, Berg et al. 2001).
The known biology of 5-HT2CRs is driven primarily by its expression and function in the
central nervous system (CNS). Serotonergic cell bodies of the dorsal raphe (DR) project to key
brain regions associated with the reward pathway such as the VTA and NAc and higher
executive function such as the PFC (Howell and Cunningham 2015, Anastasio et al. 2015), and
postsynaptic expression of the 5-HT2CRs has been reported in neuronal cell types including
dopaminergic, glutamatergic, and GABAergic. 5-HT2CRs localized to VTA dopamine neurons
have been demonstrated to play a role in binge-like eating behavior in mice, and 5-HT2CR
agonist lorcaserin was reported to induce DA neuron depolarization and increased firing rate
(Xu et al. 2017). In addition, at the LHb, serotonin has been shown to initiate a depolarizing
inward current and increase spontaneous firing in 80% of neurons in rat brain slices, which was
blocked by 5-HT2/3 receptor antagonists ritanserin, SB-200646, or ondansetron, activated by the
selective 5-HT2/3 agonists 1-(30Chlorophenyl) piperazine hydrochloride or 1-(3-Chlorophenyl)
biguanide hydrochloride, and attenuated by 2-aminoethyl diphenylborinate, a blocker of
transient receptor potential channels (Zuo et al. 2016). Furthermore, there have been ample
evidence of 5-HT2CR expression on GABAergic neurons of the VTA and SNr. Upon activation by
specific agonist, these GABAergic neurons increase firing and inhibitory output to suppress
firing of DA neurons (Bubar and Cunningham 2007, Bubar et al. 2011, Prisco, Pagannone and
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Esposito 1994, Di Matteo et al. 2000, Di Giovanni et al. 2001). Collectively, these findings
suggest 5-HT2CR activation is functionally activating and excitatory for neuronal firing, however,
the exact effects of 5-HT2CR activation on RMTg neuron functions are entirely unknown and
have yet to be studied and demonstrated.
4.1.2 The Runway Operant Paradigm and Cocaine’s Bivalent Motivational Effects
The operant runway task has long been a tool for the study of goal-directed motivated
behavior (Crespi 1942, Hull 1934). In animal studies, the run time required for the subject to
traverse the alley has been used as an index of the animal’s motivation to seek the reinforcer
that is made available upon goal box entry. Additionally, based on the classic runway work of
Crespi, it was observed that a change in the magnitude of the reinforcer delivered in the goal
box resulted in a shift or change in run time upon the next trial or day, which suggested a
means of dissociating the impact of motivation versus reinforcement. Specifically, it was
construed that the running speed and time measured on any given day is related to or reflect
motivation while the change in running speed and time from one trial to the next reflects
reinforcement.
To date, runway operant self-administration has been established in rats behaving to
obtain a variety of drug reinforcers including IV cocaine (Ben-Shahar et al. 2008, Deroche, Le
Moal and Piazza 1999, Ettenberg and Bernardi 2006, Ettenberg and Geist 1993, Ettenberg and
Geist 1991, Heinrichs et al. 1998, Wakonigg et al. 2003b), IV opiate receptor agonists such as
heroin, morphine, remifentanil, and alfentanil (Crespo et al. 2006, Ettenberg, MacConell and
Geist 1996, McFarland and Ettenberg 1995, Wakonigg et al. 2003b), IV nicotine (Cohen and
Ettenberg 2007), IV methylenedioxymethamphetamine (MDMA) (Wakonigg et al. 2003a), IV
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“speedball” (heroin and cocaine) (Guzman and Ettenberg 2004), as well as subcutaneous (SC)
amphetamine (Ettenberg 1990), SC morphine (Zernig et al. 2002), and both
intracerebroventricular and intracranial infusions of cocaine (Guzman and Ettenberg 2007).
With almost all drugs tested, subjects run the corridor faster as trials progressed. However,
cocaine produced the unique behavioral profile in which animals exhibit comparable start
latencies, but they take progressive longer to reach goal box over training trials and days. Data
from photobeam pairs lining the base of the runway revealed that animals are not traversing
the corridor more slowly, but rather acquire an increasing number of stop-and-retreat behavior
in which an animal would approach the goal box, stop, and then retreat back to the start box
(Ettenberg and Geist 1991, Jhou et al. 2013). To date the measure of the number of reversals is
thought to reflect the presence of both positive and negative associations with cocaine infusion
in the goal box. This interpretation is consistent with the observation that when the goal box
contains only aversive stimuli such as shock or purely aversive drugs, animals remain in start
box and would not approach goal box at all. In addition, when the very same animals that
exhibit reversals in runway corridor are placed into a two-compartment apparatus consisting of
only the start and goal boxes, they spend more time in the goal box, indicating that these
animals are still receptive to cocaine’s rewarding effects (Ettenberg and Geist 1991).
Furthermore, reversals and reluctance toward the goal box is not attributed to some unknown
aversive properties of the goal box itself because no retreats were observed when an identical
apparatus was used to assess goal-seeking behaviors of animals running for IV saline or heroin
(Ettenberg et al. 1996).
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In contrast to the lever-based cocaine self-administration paradigm, the runway task
also has the following additional advantages. First, the single infusion of cocaine in the runway
task helps to better isolate the aversive effect of cocaine. Second, in the runway protocol
motivation (run time) and the number of reversals are measured before cocaine infusion, thus
allowing the assessment of these constructs in a drug-free state without the potentially
confounding effects of the drug such as cocaine’s psychomotor stimulant and sensitization
properties. Third, the limited availability of cocaine resembles more early drug use in humans.
In summary, the runway operant task is suitable for studying the neurobiological basis of the
bivalent motivational properties of cocaine that may together determine the propensity and
course of cocaine use and abuse. In the current study we hypothesize 5-HT2CR function at the
RMTg is critical for cocaine’s aversive effect. If this were the case, blocking 5-HT2CR function at
the RMTg will abolish aversive and reversal behaviors in the runway operant paradigm.

4.2 Results
4.2.1 Serotonin and Specific 5-HT2CR Agonist Ro60-0175 Excite RMTg Neurons
First we asked whether there may be active serotonin receptor function on individual
RMTg neurons by using a pressure-driven drug ejection system to locally apply or “puff” 5-HT.
As shown in Figure 4.1A-B, we found puffing of 1 mM 5-HT for a duration of 15 ms rapidly
increased tonic firing frequency of RMTg neurons. Under pre-puff condition, the firing rate was
variable (n=6, 7 ± 1 Hz, range 0-12 Hz), and local application of 5-HT transiently increased the
firing rate to 40 ± y Hz. Perfusion of TTX (1 µM) blocked tonic firing without affecting 5-HT
evoked depolarization, confirming the membrane depolarizing effect of 5-HT is independent of
voltage-gated sodium and presynaptic conduction and firing of action potentials, whereas bath
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application of SB242084, a specific 5-HT2CR antagonist, completely abolished depolarization,
suggesting the observed 5-HT induced excitation may be mediated by 5-HT2CRs. The same
conclusion may be reached when we patched RMTg neurons in voltage clamping mode and
exposed them to 5-HT. Puffing of 5-HT induced inward current of significant but various
magnitudes (n=5), while exposure to specific antagonist SB242084 blocked 5-HT induced
inward current, supporting RMTg neuron activating response to 5-HT is mediated solely by 5HT2CRs (Figure 4.1C).
To further demonstrate RMTg neurons may be excited upon activation of 5-HT2CRs, we
next exposed ex vivo RMTg neurons to specific 5-HT2CR agonist Ro60-0175. As shown in Figure
4.2A-B, bath application of Ro60-0175 evoked inward currents that rose slowly and lasted for
more than five minutes, and such activating response was blocked by the co-application of
specific antagonist SB242084 but not TTX. In addition, puffing of specific agonist Ro60-0175 (15
ms, 300 µM) resulted in excitatory response similar to that elicited by 5-HT. Specifically, Ro600175 increased spontaneous firing (n=6) that is not dependent on neurotransmission and
depolarization that may be blocked by co-application of antagonist SB242084 (Figure 4.2C-D).
Having shown that excitatory response of RMTg neurons may be evoked by both 5-HT
and Ro60-0175 in a 5-HT2CR function specific manner, we next tested whether transient
receptor potential channels (TRPCs) may be involved in this response since previously they have
been shown to be downstream of 5-HT2CR activation at the lateral habenula (2015 Zuo). We
first tested whether Ro60-0175-induced inward current was due to TRPC3 conductance using
the selective TRPC3 antagonist PYR3 (20 µM). As expected, Ro60-0175 puff resulted in a large
(200 pA) and short-lasting (200 ms) inward current in RMTg neurons, however, as shown in

60

Figure 4.2E, only two of the six recorded neurons displayed a 40% reduction of the inward
current in RMTg neurons when PYR3 was applied for at least 10 minutes. Given the inability of
TRPC3 antagonist to block Ro60-0175 induced inward current, we then tested whether the
inward current evoked by Ro60-0175 may be due to TRPC4/5, using the selective antagonist
M084. As expected Ro60-0175 puff resulted in significant and short-lasting inward current on
RMTg neurons, however, in all recorded RMTg neurons (n=6), this current was entirely
eliminated by the selective TRPC4/5 antagonist M084 (20 µM), strongly suggesting TRPC4/5
containing channel complexes are responsible for 5-HT2CR mediated inward current.
Next, since Ca++ ions are one of the major inward charge carriers of non-selective cation
currents and rise in Ca++ has been implicated in the signaling cascades involved in the induction
of early response genes such as cfos following 5-HT2CR activation (2021 Yao), we investigated
whether 5-HT2CR activation results in the rise of [Ca++] in RMTg neurons by monitoring
intracellular calcium during focal application of Ro60-0175 (300 µM) in RMTg brain slices
transfected with GCAMP7 in the presence of TTX (1 µM). We found as shown in Figure 4.2F,
puffing of Ro60-0175 (20 seconds) elicited a rise in Ca++ in RMTg neurons, confirming that 5HT2CR activation is coupled to an intracellular rise in Ca++. Lastly, we used the conditioned place
aversion paradigm to test whether site specific excitation of RMTg 5-HT2CRs may be sufficient to
confer aversive response. As shown in Figure 4.2G, we found direct microinfusion of 5-HT2CR
agonist Ro60-0175 to bilateral RMTg was sufficient to confer conditioned place aversion in the
drug paired chamber (unpaired two-tailed t test, vehicle, n=8, 2.051 ± 4.235 vs. Ro60-0175,
n=8, -22.75 ± 8.528, t(14)=2.604, p=0.0208).
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4.2.2 Cocaine Elicits Robust cfos expression in htr2c RMTg Neurons, and Activates RMTg
Neurons in a 5-HT2CR Function Dependent Manner
Many prior studies documented robust cFos expression at the RMTg following exposure
to psychostimulants including cocaine (Geisler et al. 2008, Jhou et al. 2013, Sanchez-Catalan et
al. 2017, Smith et al. 2019). In the current study, toward testing the hypothesis that 5-HT2CR
function at the RMTg plays a role in RMTg cFos response to cocaine, we used FISH RNAscope to
examine the extent of co-localization between htr2c and cfos at the RMTg following cocaine
exposure. As shown in Figure 4.3A-G, we first found in comparison to animals that were
subjected to the control treatment of a single intraperitoneal injection of saline, injection with
cocaine elicited a significantly higher percentage of cfos positivity in htr2c neurons at the RMTg
(unpaired two-tailed t test, saline, n=6, 10.83 ± 1.845 vs. cocaine, n=7, 26.60 ± 3.259,
t(11)=6.611, p < 0.0001; Figure 4.3G). Next to examine whether htr2c expression may be a
sufficient condition for inducing cfos after cocaine exposure, we enumerated all htr2c neurons
at the RMTg from seven individual subjects, and found that of all 2748 RMTg htr2c neurons
identified, 1022 (37.2%) of them (group range of cfos/htr2c of individual animals 27.5-48.3%,
group mean 36.8%) were cfos positive. Conversely, when we examined a total of 952 cfos
positive neurons from the same seven animals, we found 902 (94.7%) of them (group range of
htr2c/cfos of individual animals 89.1-99.0%, group mean 94.9%) were htr2c positive (Figure
4.3H). While these results suggest htr2c may be a necessary but not sufficient condition for cfos
expression, we further found that in cfos positive htr2c neurons, for each quantile increase of
htr2c density, there is a significant corresponding increase in cfos density (Kruskal-Wallis test,
p<0.0001, Dunn’s multiple comparisons test, 1st vs. 2nd p<0.0001, 1st vs. 3rd p<0.0001, 1st vs. 4th
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p<0.0001, 2nd vs. 3rd p=0.0027, 2nd vs. 4th p<0.0001; Figure 4.3I), suggesting that while htr2c
alone may not be sufficient for cfos induction, in neurons where possibly other conditions
requisite for cfos expression are met, htr2c may have a “dosage” contribution to RMTg
neuronal activation or cfos expression following cocaine.
To follow up on the hypothesis that 5-HT2CR function is necessary for cfos expression
following cocaine exposure, we delivered AAVs encoding scrambled versus htr2c specific shRNA
to the RMTg then examined cfos expression at the RMTg following cocaine exposure. As shown
in Figure 4.4A-I, infection with htr2c shRNA, compared to scrambled shRNA, resulted in loss of
htr2c and cfos expression after cocaine exposure. The importance of 5-HT2CR function for RMTg
excitatory response to cocaine is further corroborated by the findings that htr2c knockdown
effectively abolished RMTg htr2c expression (Figure 4.4I, unpaired two-tailed t test, scrambled
shRNA n=4 1.053 ± 0.000 vs. htr2c shRNA n=4 0.3000 ± 0.000, t(6)=9.212, p<0.0001) and neuron
functional response to 5-HT2CR agonist (Figure 4.5A-C), and in an ex vivo system, individual
RMTg neurons lost excitatory response to cocaine in the presence of 5-HT2CR antagonist
SB242084 (Figure 4.5D-E).
4.2.3 Pharmacological Antagonism of RMTg 5-HT2CRs Blocks Cocaine Conditioned Avoidance
and Place Aversion
We next tested the effects of intra-RMTg microinfusion of SB242084 on the runway
operant task, which has been shown to be sensitive to cocaine’s aversive effects, and in which
many animals traversing a 5-foot corridor to reach a goal box where cocaine is infused show
increasing run latencies as trials progress. We found relative to vehicle, SB242084 microinfused
to RMTg abolished increase in runway latencies. Repeated measures two-way ANOVA found
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main effects of trials (F3.450, 65.55=7.129, p=0.0002), treatment (vehicle vs. SB242084, F1, 19=10.72,
p=0.0040; n=10, 11), and treatment X trial interaction (F6, 114=2.357, p=0.0349; Figure 4.6B).
Prior studies showed that conditioned avoidance effects of cocaine in this task are most
prominent in trials 4-7 (Jhou et al. 2013), and indeed, relative to vehicle, SB242084 reduced
average runway latency of these trials (Mann-Whitney test, 225.6 ± 85.64 vs. 24.96 ± 9.42,
p=0.0242; Figure 4.6C), and produced a trend toward fewer reversals (Mann-Whitney test,
3.900 ± 1.781 vs. 0.1818 ± 0.1016, p=0.0535; Figure 4.6D).
Because our antagonist treatment was applied prior to the beginning of each runway
trial, we could not determine whether 5-HT2CR antagonism blocked learning versus recall of
cocaine avoidance (or both). Hence, we microinfused vehicle or SB242084 into the RMTg of a
cohort of animals that had already undergone seven trials of runway training. We found no
significant difference in runway latency between vehicle- and SB242084-treated conditions
(paired two-tailed t test, vehicle, n=12, 464.1 ± 102.6 vs. SB242084, n=12, 462.6 ± 102.2,
t(11)=0.01345, p=0.9895; Figure 4.6E), indicating that microinfusion of SB242084 has no effet
on recall of previously learned avoidance responses. We also found no effect of SB242084 on
locomotor activity, indicated by the total number of photobeam interruptions enumerated in a
30-minute period, in a novel chamber (paired two-tailed t test, vehicle 452.8 ± 19.70 vs.
SB242084 487.0 ± 33.71, t(9)=0.9368, p=0.3733; n=10; Figure 4.6F), indicating that it was
unlikely that SB242084 had altered runway operant task latency via non-specific effects on
exploratory or locomotive ability.
Because cocaine exhibits both rewarding and aversive effects, it may be argued the
reduction in runway latency after 5-HT2CR antagonist treatment at the RMTg was due to
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enhanced appetitive rather than attenuated avoidance responses to cocaine. Hence, we next
used the CPP/A paradigm to examine the effects of RMTg 5-HT2CR blockade on the bivalent and
associative learning effects of cocaine. We and others have previously demonstrated that the
bivalent motivational effects of cocaine can be temporally separated (Jhou et al. 2013,
Ettenberg et al. 2015). Specifically, animals developed place preference when conditioned to
the drug-paired chamber immediately after cocaine exposure, but developed place aversion if
conditioned to these chambers 15 minutes after cocaine exposure. We replicated these earlier
results by testing for CPP/A after 8 conditioning sessions (4 per side) in which animals were
given intravenous cocaine or saline 0 or 15 minutes prior to placement into drug- vs salinepaired chambers for 15 minutes. These animals were further subdivided into groups receiving
microinfusion of either vehicle or the specific 5-HT2CR antagonist SB242084 bilaterally into
RMTg prior to cocaine treatment. We found, as expected, that vehicle microinfused animals
showed preference and aversion to cocaine at the immediate (0-15 min) and delayed (15-30
min) conditions, respectively. Furthermore, SB242084 had no effect on immediate preference
scores, but reversed the delayed aversive conditioning to a preference. Two-way ANOVA found
significant effects of microinfusion treatment (vehicle vs. SB242084, F1, 21=7.4, p=0.0126; n=12,
13), time of conditioning after cocaine infusion (0-15 vs. 15-30 min, F1, 21=11.8, p = 0.0024;
n=13, 12), and interaction (F1, 21=8.3, p=0.0089). Post hoc pairwise comparisons (Tukey
correction) found significant differences between 0-15 min vehicle and 15-30 min vehicle (20.72
± 7.925 % vs. -24.85 ± 6.708 %, p=0.0013; n=6, 6), between 15-30 min vehicle and 15-30 min
SB242084 groups (-24.85 ± 6.708 % vs. 15.58 ± 4.538 %, p=0.0043; n=6, 6), but no significant
difference between 0-15 min vehicle and 0-15 min SB242084 (20.72 ± 7.925 % vs. 19.60 ±
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8.356 %, p=0.9995; n=6, 7; Figure 4.6G). Hence, 5-HT2CRs at the RMTg likely play necessary and
selective roles in cocaine’s aversive but not appetitive effects.
4.2.4 Expression of htr2c Gene Specific shRNA at the RMTg, but not at the IPN nor VTA,
Attenuates Cocaine Conditioned Avoidance
Although SB242084 is selective for 5-HT2CRs, it has some affinity (100-fold less) for 5HT2ARs, which are also expressed in RMTg, albeit at reduced levels Figure 4.7A-Da’’’). In
addition, 5-HT2CRs are expressed both pre- and postsynaptically at the RMTg, and at sites just
rostral and ventromedial to the RMTg such as the VTA and IPN, respectively. To address exactly
which receptors and anatomic sites contributed to our observed effects, we developed AAVs
encoding a fluorescent marker along with htr2c-specific or scrambled control shRNAs, thereby
achieving more gene-, compartment-, site-specific, and verifiable targeting and blockade of
RMTg 5-HT2CRs. We found injections into RMTg of AAV containing htr2c shRNA abolished
progressive increase in latency to obtain cocaine on the runway task. Repeated measures twoway ANOVA found main effect of virus (scrambled vs. htr2c, F1, 21=4.977, p=0.0367; n=12, 11)
and of group X trial interaction (F6, 126=3.418, p=0.0037; Figure 4.8B). During trials 4-7, relative
to the scrambled shRNA, htr2c shRNA reduced average runway latency (Mann-Whitney test,
322.8 ± 94.04 vs. 42.51 ± 17.34, p=0.0106; Figure 4.8C) and the number of reversals (MannWhitney test, 3.854 ± 1.275 vs. 1.205 ± 0.5924, p=0.0459; Figure 4.8D). Virus injections into
either VTA or IPN revealed no significant effects of shRNA on the progression and magnitude of
runway latencies and the number of reversals (VTA n=9, 10; F1, 17=0.0844, p=0.7749; 4-7 ave.
latency 237.8 ± 81.47 vs. 233.1 ± 90.04, p=0.8421; 4-7 ave. reversals 6.139 ± 2.306 vs. 3.825 ±
1.482, p = 0.5766; IPN n=9, 8; F1, 15=0.9048, p=0.3566; 4-7 ave. latency 208.7 ± 75.97 vs. 376.0 ±
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116.9, p=0.3213; 4-7 ave. reversals 4.750 ± 2.233 vs. 6.781 ± 1.728, p=0.3305; Figure 4.9).
Hence, htr2c shRNA blocks both electrophysiological and behavioral functions of 5-HT2CR, with
the latter effects being selective for receptors at the postsynaptic RMTg versus the adjacent
VTA, and IPN.
To determine whether htr2c knockdown might have influenced cocaine-seeking via
more generalized effects on other variables of motivated behavior, we examined its effects on
additional tasks. We found no effect of htr2c knockdown on locomotion in a novel environment
(unpaired two-tailed t test, scrambled 808.4 ± 74.15 vs. htr2c 800.5 ± 73.80, t(20)=0.0749,
p=0.9410; n=10, 12; Figure 4.8E), nor in the rate at which locomotor activity declined, which
reflects no effect on habituation to a novel environment (repeated measures two-way ANOVA,
time X shRNA, F5, 100=1.280, p=0.2786; Figure 4.8H). In addition, we found that htr2c knockdown
in RMTg did not alter reward-seeking for food in a progressive ratio task (breakpoint: unpaired
two-tailed t test, scrambled 133.3 ± 14.18 vs. htr2c 143.1 ± 16.11, t(25)=0.4601, p=0.6494;
n=14, 13; Figure 4.8F; lever-presses: two-way ANOVA, active vs. inactive, F1, 49=331, p<0.0001;
shRNA, F1,49=3.3, p=0.0742; lever X shRNA, F1, 49=2.2, p=0.1444; Figure 4.8I), in which food
deprived animals are required to emit increasing number of lever presses to obtain one single
vanilla pellet. These animals also did not show alterations in a punished food-seeking task in
which food deprived animals obtained vanilla pellet via single FR1 lever press that is
accompanied by a footshock that increases in intensity upon each successive trial until a
breakpoint is reached (breakpoint: unpaired two-tailed t test, scrambled 0.8736 ± 0.06376 vs.
htr2c 1.003 ± 0.08054, t(24)=1.280, p=0.2129; n=15, 11; Figure 4.8G; lever presses: two-way
ANOVA, active vs. inactive, F1, 48=241.4, p<0.0001; shRNA, F1,48=1.068, p=0.3649; lever X shRNA,
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F1, 48=0.7590, p=0.3880; Figure 4.8J). Hence, htr2c shRNA at the RMTg on cocaine conditioned
avoidance is due to alteration in the acquired motivation to obtain cocaine, but not due to
alterations in exploratory and locomotor activity, general motivation to obtain rewards, and
ability to avoid punishment.

4.3 Discussion
We demonstrated here for the first time that serotonin or specific agonist activation of
5-HT2CRs at the RMTg induces an inward current, a depolarizing change in resting membrane
potential that increases the frequency of spontaneous firing of action potentials, that the
induced inward current is largely mediated by transient receptor potential channels 4/5 but to
a much less extent 2/3, and transduction of signaling cascades downstream of 5-HT2CR
activation results in accumulation and increase in RMTg neuron intracellular Ca2+ signal. We
further tested the functional consequence of 5-HT2CR activation at the RMTg by installing
guided cannula, and then found microinfusing agonist Ro60-0175 was sufficient to induce
conditioned place aversion. However, it should be cautioned that due to proximity of the IPN to
the RMTg, and that the IPN is enriched for ht2c as well and has been implicated in nicotine
related aversion and anxiety-like behavior (Zhao-Shea et al. 2015, Wolfman et al. 2018, Morton
et al. 2018), further experiments would be needed to completely rule out the possibility that
the conditioned place aversion effect was due to 5-HT2CR function at the IPN.
Previously it was shown after ibotenic lesion of the RMTg, animals still spend less time
on the open arms but increased the percentage of open arm entries on the elevated plus maze
(Jhou et al. 2009a). In another study it was found quinolinic acid lesion of the RMTg did not
abolish cocaine conditioned place aversion but increased the number of entries to the cocaine68

paired chamber (Li et al. 2019). In both cases irreversible destruction of the RMTg increased
disinhibited engagement with innate and conditioned aversive stimuli which we speculated to
indicate deficit in impulse control. While in the current study we did not formally test the role
of 5HT2CRs at the RMTg in the impulsivity construct, we found in rats that had already
developed cocaine aversion 5HT2CR antagonist did not significantly reduce or abolish reluctance
to enter the cocaine-associated goalbox of the runway operant apparatus. While our prior
findings indicate there are elements to the RMTg structure that are irreplaceable for impulse
control or behavioral inhibition, the current study suggests 5HT2CRs at the RMT may not play a
significant role in these functions. Although alternatively, it may be the case that 5HT2CRs at the
RMTg do play a role in impulsivity, either specifically in respect to cocaine-related cues and
context or to other aversive stimuli as well, but the runway operant task employed here was
not specific or sensitive to these effects. Previous studies have implicated serotonin
neurotransmission, 5HT2ARs, and 5HT2CRs at the PFC in regulating impulsivity (Anastasio 2014).
Future studies may use a more specific and sensitive paradigm such as the one-choice serial
reaction time task to test the role of 5HT2CRs at the RMTg in the impulsivity construct.
In contrast to our prior study that showed RMTg-lesioned animals are still conditioned
by cocaine’s aversive effects to spend less time in the drug-paired chamber, curiously in the
current study 5HT2CR antagonism at the RMTg during cocaine’s “aversive phase” resulted in
conditioned place preference. While it is possible that chronic absence of the whole RMTg
structure had prompted other neural networks to substitute the function of encoding cocaine’s
aversive effects, our finding here is reminiscent of prior studies that showed IV SB242084
infusions reinforce operant response in squirrel monkeys that were previously trained to self-
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administer cocaine and RMTg inactivation drives real time place preference (Manvich et al.
2012a, Smith et al. 2019). These findings suggest inhibition of 5HT2CRs and the RMTg may
produce stimulatory effects and positive motivational valence by antagonizing serotonin and
afferents at the RMTg that contribute to or constitute a basal level of “aversiveness”. Hence the
ability of SB242084 to confer place preference during cocaine’s “aversive phase” may be due to
blockade of cocaine-induced serotonin at the RMTg unmasking rewarding effects of cocaine
that possibly perseveres from the 0-15-minute time period, or blockade of tonic serotonin
neurotransmission at the RMTg that results in dampened activities of RMTg neurons and
positive affective response. The sufficiency of 5HT2CR antagonism at the RMTg to confer
conditioned place preference in a drug-free paradigm remains to be tested. Future studies may
be aimed at characterizing the magnitude or degree of tonic serotonin neurotransmission at
the RMTg in response to other contexts and stimuli, the roles of tonic and phasic serotonin
release at the RMTg in determining or conferring motivational valence, and whether they
contribute to or regulate the processing of and affective responses to other aversive stimuli
such as foot-shock or an anxiogenic context such as the open arms of elevated plus maze.
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Figure 4.1. 5-HT2CR function is necessary for serotonin excitation of RMTg neurons. A.
Representative traces of RMTg neuron spontaneous firing of action potentials and resting
membrane potential in the presence of TTX and 5-HT2CR antagonist SB242084 before and after
puffing of serotonin. B. Summary of firing rates before and after local application of 5-HT. C.
Summary of magnitude of inward currents induced by serotonin in the absence versus presence
of SB242084. Figure 4.1(A-C) experiments conceived by YSC and Jeffrey Parilla-Carrero PhD
(JPC). JPC designed and performed the experiments and obtained data.
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Figure 4.2. Activation of 5-HT2CRs by specific agonist Ro60-0175 excites RMTg neurons. A.
Representative traces of inward current induced by bath application of Ro60-0175 in the
absence (green) versus presence (blue) of antagonist SB242084. B. Bath application of Ro600175 induces inward current that is blocked by antagonist SB242084. C. Representative traces
of RMTg neuron spontaneous firing of action potentials and resting membrane potential in the
presence of TTX and 5-HT2CR antagonist SB242084 before and after puffing of agonist Ro600175. D. Summary of firing rates before and after local application of Ro60-0175. E. Ro60-0175
activation of 5-HT2CRs at the RMTg is coupled to TRPC4/5 but not TRPC3 channels. F. Local
application of Ro60-0175 on RMTg neurons induces increased intracellular Ca++ level detected
by calcium sensor GCAMP7. G. Activation of 5-HT2CRs at the RMTg by agonist Ro60-0175 is
sufficient to confer conditioned place aversion. Unpaired two-tailed t test, *p=0.0208. Figure
4.2(A-F) experiments conceived, designed, performed, and data obtained by JPC.

72

Figure 4.3. (A-F) htr2c neurons at the RMTg express abundant cfos following cocaine
exposure. G. Summary of cfos expression in htr2c neurons at the RMTg given IP saline versus
cocaine injection. H. Summary of cocaine cfos and htr2c co-localization at the RMTg. I.
Summary of cocaine cfos as a function of htr2c density. A total of 1163 htr2c positive cells
enumerated from 6 RMTg sections of two rat subjects. Dunn’s multiple comparisons test,
**p=0.0027. ****p<0.0001.
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Figure 4.4. (A-Ha’’’’) Blockade of 5-HT2CR function via AAV mediated shRNA knockdown of htr2c at the RMTg abolishes cfos
expression following cocaine exposure. I. Summary of htr2c expression after injection of AAVs encoding scrambled versus htr2c
specific shRNA to the RMTg. Unpaired two-tailed t test, ****p<0.0001.
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Figure 4.5. htr2c shRNA abolishes RMTg neuron excitatory response following 5-HT2CR
activation, and 5-HT2CR function is critical for RMTg excitatory response to cocaine. A.
Representative traces of inward current induced by Ro60-0175 exhibited by RMTg neuron
obtained from animals treated to scrambled (green) versus htr2c (blue) shRNA. B-C. Summary
of inward currents induced by Ro60-0175 exhibited by RMTg neurons obtained from animals
treated to scrambled (green) versus htr2c (blue) shRNA. D. Representative traces of RMTg
neuron depolarization in response to bath application of cocaine in the absence (orange) versus
the presence (blue) of SB242084. E. Summary of RMTg neuron depolarization in response to
bath application of cocaine in the absence (orange) versus the presence (blue) of SB242084.
Figure 4.5(A-C) experiments conceived, designed, performed, and data obtained by YSC and
JPC. Figure 4.5(D-E) experiments conceived, designed, performed, and data obtained by JPC.
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Figure 4.6. RMTg 5-HT2CRs play a necessary and specific role in the negative associative effect
of cocaine. A. Representative image showing tracts of guided cannula and microinfusion
injectors that reached the RMTg nuclei visualized by Foxp1 expression (dark blue staining). B-D.
RMTg 5-HT2CR function blockade by antagonist SB242084 reduced latency and the number of
reversals before obtaining cocaine in the runway operant task. **Two-way ANOVA significant
effect of SB242084 infused, p=0.004. *Mann-Whitney test, p=0.0242. E. RMTg 5-HT2CR function
blockade by antagonist SB242084 does not impact the recall or expression of negative affective
behavior in animals that had already developed or acquired avoidance response to cocaine in
the runway operant task. F. RMTg 5-HT2CR function blockade by antagonist SB242084 does not
impact propensity to ambulate or locomotor activity induced by exposure to or placement in a
novel chamber. G. RMTg 5-HT2CR function blockade by antagonist SB242084 reduced cocaine
conditioned place aversion but not cocaine conditioned place preference. Tukey’s multiple
comparisons test, 0-15 vs. 15-30 vehicle, **p=0.0013; 15-30 vehicle vs. 15-30 SB242084,
**p=0.0043.
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Figure 4.7. Expression of htr2c is much more abundant than that of htr2a at the RMTg. A-D.
Representative 10x magnification images of htr2a and htr2c expression at the RMTg. Da’-Da’’’.
Red arrows indicate RMTg cells that show htr2c positivity. Green arrows indicate RMTg cells
that show htr2c positivity. Yellow arrows indicate RMTg cells that are double positive for htr2c
and htr2a.
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Figure 4.8. Blockade of 5-HT2CR function at the RMTg by htr2c shRNA reduced operant
response to obtain cocaine but not locomotor activity and seeking of non-drug reinforcer. A.
Representative image showing placement of AAVs encoding scrambled or htr2c shRNA at
bilateral RMTg. B-D. Blockade of RMTg 5-HT2CR function by htr2c shRNA reduced latency and
the number of reversals before obtaining cocaine in the runway operant task. E + H. Blockade
of RMTg 5-HT2CR function by htr2c shRNA had no effect on locomotor activity induced by novel
chamber. B. Two-way ANOVA significant effect of htr2c shRNA *p=0.0196. C. Mann-Whitney
test, *p=0.0106. D. Mann-Whitney test, *p=0.0459. F + I. Blockade of RMTg 5-HT2CR function by
htr2c shRNA had no effect on motivation to obtain non-drug reinforcer. I. Two-way ANOVA
significant active vs. inactive lever effect, ****p<0.0001. G + J. Blockade of RMTg 5-HT2CR
function by htr2c shRNA had no effect on operant responding that was reinforced by non-drug
reinforcer but deterred by shock. J. Two-way ANOVA significant active vs. inactive lever effect,
****p<0.0001.
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Figure 4.9. Blockade of VTA or IPN 5-HT2CR function by htr2c shRNA had no effect on
avoidance response to cocaine.
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Chapter 5
The Roles of Individual Differences in Sensitivity to
Cocaine’s Aversive Effects and RMTg 5-HT2CR Function in
Operant Responding for Cocaine
5.1 Introduction
In contrast to the runway operant paradigm, which bears more resemblance to the
initial acquisition stage of drug abuse where exposures to substance may be further apart and
lower in dosage, the lever-based drug self-administration paradigm additionally models later
stages of drug abuse such as binging, extinction, and relapse. In the lever-based drug selfadministration paradigm, animals are trained to emit a lever press to obtain drug (Clark,
Schuster and Brady 1961, Weeks 1962), and the number of lever presses emitted and the
amount of drug obtained are measured to indicate the reinforcing property of a drug, a key
factor that influences the risk of abuse liability (Balster and Bigelow 2003, Johanson 1990,
Panlilio and Goldberg 2007). Relapse, which is a main problem for treatment of drug addiction
in humans, is typically modeled and studied with animals that are first trained to self-administer
a drug, and resumption of drug seeking is assessed after an experiment-imposed extinction of
the drug-reinforced responding in the self-administration chambers (Shaham et al. 2003,
Bossert et al. 2013, Venniro, Caprioli and Shaham 2016). Studies using the reinstatement model
have shown that after extinction of the drug-reinforced responding, drug seeking can be
reinstated after exposure to drug associated discrete cues and contexts (See 2002, Crombag
and Shaham 2002). The neural circuits of reinstatement have been mapped to structures
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including the extended amygdala, prefrontal cortex, and mesolimbic DA system (de Wit and
Stewart 1981, de Wit and Stewart 1983, Kalivas and McFarland 2003, Shaham et al. 2003,
Rocha and Kalivas 2010).
Not all individuals exposed to drugs of abuse are equally susceptible to developing
addiction (Tsuang et al. 1998, Van Etten and Anthony 1999, Deroche-Gamonet, Belin and Piazza
2004, Ellenbroek et al. 2005). One predisposing factor that may determine susceptibility and
even exist before drug exposure is behavioral sensitivity to the aversive properties of abused
drugs, which have been implicated to influence seeking of morphine, cocaine, nicotine, and
alcohol (Wheeler et al. 2015, Riley 2011). Previously, cocaine’s aversive effects have been
demonstrated to vary between individual animals and strongly influence drug-seeking
behaviors in both the runway and lever-based cocaine operant responding paradigms (Jhou et
al. 2013, Ettenberg et al. 2015). Specifically, while cocaine conditioned place preference is
correlated with higher amount of drug intake, conversely, it was found animals exhibiting
conditioned place aversion to cocaine are less likely to acquire operant drug-seeking behavior
(Ettenberg et al. 2015).
We have shown blockade of 5-HT2CRs at the RMTg attenuates cocaine conditioned
avoidance and place aversion, but it is not known whether RMTg 5-HT2CRs are regulated
endogenously to determine aversive response to cocaine. In addition, the roles of RMTg and
RMTg 5-HT2CRs in further stages of cocaine addiction have never been investigated. Since the
runway task delivers relatively low amounts of cocaine (only one dose per trial), it only models
early acquisition of drug-seeking behavior, but not later stages such as extinction and
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reinstatement, which is an important variable as the propensity to relapse is a major obstacle
to effective addiction treatment.

5.2 Results
5.2.1 5-HT2CR function at the RMTg is Abolished in High Cocaine-Seeking Animals
Toward addressing these questions, we first examined the functional status of RMTg 5HT2CRs in animals that displayed individual variation in aversive response to cocaine. On
average, rats performing the runway operant cocaine-seeking paradigm show increasing
latencies to obtain cocaine, but we also saw large individual variations in the degree of increase
(Figure 4.6B and 5.1A-B), consistent with our prior data showing that SD rats exhibit a bimodal
distribution of “high-avoider” and “low-avoider” animals with high and low run latencies
respectively (Parrilla-Carrero et al. 2021). Using slice electrophysiology techniques, we found
evidence for marked reduction of RMTg 5-HT2CR function in low- versus high-avoider animals.
Specifically, as shown in Figure 5.1C, bath application of agonist 5-HT2CR induced inward in
RMTg neurons obtained from high- but not low-avoider animals. Furthermore, as shown in
Figure 5.1D, bath application of cocaine induced depolarization in membrane potential in RMTg
neurons obtained from high- but not low-avoider animals. Hence, we found 5-HT2CR function at
the RMTg is abolished in low-avoiders, and 5-HT2CR function is required for depolarization of
RMTg neurons in response to cocaine exposure, consistent with our current findings that
blockade or knockdown of this receptor produces a low-avoidance phenotype on the runway
task.
5.2.2 Aversive Response to Cocaine and 5-HT2CR function at the RMTg are Correlated with
Attenuated Relapse Seeking
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Next to test the roles of variation in early acquisition and RMTg 5-HT2CRs in later-phase
measures of drug-seeking and addiction, we used the runway task to generate low- and highavoiders, then subdivided them to receive scrambled or htr2c shRNA into the RMTg prior to
testing under the lever-based cocaine self-administration (SA) paradigm (Figure 5.1E). In
animals receiving scrambled shRNA in RMTg, during the first three sessions of cocaine selfadministration, high avoiders obtained fewer cocaine infusions than low-avoiders (Fig. 5.2A, B),
and showed a trend toward fewer lever presses (Fig. 5.2D, E), reflecting reduced propensity of
these animals to acquire drug taking. After further training, cocaine infusions and lever presses
eventually equalized between groups (Fig. 5.2C, F). After extinction, during which groups did
not differ (Fig. 5.2G), tests of cue-induced reinstatement revealed lower levels of reinstatement
in high than low avoiders receiving scrambled shRNA (Fig. 5.2H), again reflecting reduced drugdirected behavior.
In contrast to scrambled controls, in animals receiving htr2c shRNA at the RMTg, high
avoiders showed greater responses during the first 3 days of SA training relative to lowavoiders, the opposite of what was seen in the scrambled control group, reflecting a loss of the
protective influence afforded by the high-avoider phenotype. Figure 5.2A shows the average
number of infusions obtained in the first three SA sessions. Two-way ANOVA identified
significant effect of runway phenotype X shRNA interaction (F1, 36=14.97, p = 0.0004). Post hoc
pairwise comparisons (Tukey correction) found significant difference between low versus high
avoiders receiving scrambled shRNA (19.55 ± 4.045 vs. 7.070 ± 2.732, p = 0.0320; n = 11, 10),
and between scrambled versus htr2c shRNA in high (7.070 ± 2.732 vs. 24.00 ± 4.947, p = 0.0067;
n = 10, 10) but not in low avoiders (19.55 ± 4.045 vs. 12.50 ± 5.715, p = 0.3678; n = 11, 9). Figure

83

5.2D shows the average number of lever presses emitted in the first three SA sessions. Two-way
ANOVA identified significant effect of runway phenotype X shRNA interaction (F1, 36 = 13.02, p =
0.0009). Post hoc pairwise comparisons (Tukey correction) found significant differences in lever
pressing between scrambled and htr2c shRNA groups in high (20.47 ± 10.72 vs. 171.3 ± 65.43, p
= 0.0103; n = 10, 10), but not in low avoiders (53.64 ± 20.21 vs. 39.29 ± 31.31, p = 0.3021; n =
11, 9), and between low versus high avoiders receiving htr2c knockdown (35.18 ± 27.92 vs.
171.3 ± 65.43, p = 0.0198; n = 9, 10). The latter was due to a marked increase in lever pressing
in the knockdown high avoider group during the 20 second timeout period after each infusion,
measured as lever presses emitted per infusion (Fig. 5.3C, post hoc pairwise comparisons with
Tukey correction, 1.71 ± 0.473 vs. 4.24 ± 1.198, p = 0.0382; n = 9, 10). Notably, although
scrambled control rats showed differences between high and low avoiders in the number of
infusions, the number of lever presses between these groups did not quite reach significance
(post hoc pairwise comparisons with Tukey correction, 53.64 ± 20.21 vs. 20.43 ± 10.73, p =
0.2073; Mann-Whitney test, p = 0.0533; n = 11, 10). Except for between low avoiders receiving
scrambled versus htr2c shRNA (Fig. 5.3A, post hoc pairwise comparisons with Tukey correction,
14.12 ± 3.355 vs. 5.31 ± 1.341, p = 0.0412; n = 11, 9), and as mentioned above between low and
high avoiders receiving htr2c shRNA, no differences were found in the average inactive or active
lever presses per infusion during acquisition (Fig. 5.3A-D), nor in cocaine-induced locomotion in
a novel environment (Fig. 5.3E), suggesting differences in acquisition of cocaine selfadministration, especially those observed between low and high avoiders receiving scrambled
shRNA, and high avoiders receiving scrambled versus htr2c shRNA, are due to RMTg 5-HT2CR
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modulation of cocaine’s aversive effect rather than variation in generalized motoric output that
is not goal or drug-directed.
Longitudinal analysis of the number of cocaine infusions obtained and the number of
lever presses emitted in the first three and last ten self-administration sessions also found
compared to low avoiders, high avoiders less readily increase cocaine consumption over time or
SA sessions, and htr2c shRNA at the RMTg increases drug consumption and seeking in high but
not in low avoiders. Figure 5.2B shows the median number of cocaine infusions obtained during
SA sessions. Repeated measures three-way ANOVA identified significant interaction effects
between runway phenotype X shRNA (F1, 29 = 4.532, p = 0.0419), and sessions X runway
phenotype X shRNA (F12, 348 = 3.449, p < 0.0001), corroborating htr2c shRNA treatment had
differential impact on the acquisition and development of cocaine consumption or binging
depending on runway phenotype. Subsequently, repeated measures two-way ANOVA identified
significant interaction effect of SA session X runway phenotype between low and high avoiders
receiving scrambled shRNA (F12, 168 = 2.002, p = 0.0268; n = 8, 8) and effect of htr2c shRNA in
high (F1,14 = 10.10, p = 0.0067; n = 8, 8) but not in low avoiders (F1,15 = 0.2827, p = 0.6027; n = 8,
9). Figure 5.2E shows the median number of lever presses emitted during SA sessions, which
echoes to some extent findings obtained from analysis of cocaine infusions. Specifically,
repeated measures three-way ANOVA found interaction effects of runway phenotype X shRNA
(F1, 29 = 5.417, p = 0.0271), and sessions X runway phenotype X shRNA interaction (F12, 348 =
3.296, p = 0.0002; Figure 5.2E). Subsequently, repeated measures two-way ANOVA did not find
significant effects of runway phenotype between low and high avoiders receiving scrambled
shRNA (F1,14 = 3.178, p = 0.0963; n = 8, 8) nor interaction effect of SA session X runway
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phenotype (F12, 168 = 1.534, p = 0.1165), but identified effect of htr2c shRNA in high (F1,14 =
10.64, p = 0.0057; n = 8, 8) but not in low avoiders (F1,15 = 0.04290, p = 0.8387; n = 8, 9).
Lastly, we found that high-avoiders emitted fewer lever presses during cue-induced
reinstatement in the scrambled control groups. Furthermore, htr2c knockdown in high but not
low avoiders increased the number of presses relative to scrambled controls. A two-way
ANOVA revealed significant effects of runway phenotype x shRNA interaction (F1, 23=6.244, p =
0.0200) and shRNA (F1, 23 = 8.788, p = 0.0069). Post hoc pairwise comparisons (Tukey correction)
revealed significant differences between low and high avoiders receiving scrambled shRNA
(44.71 ± 8.89 vs. 14.17 ± 4.053, p = 0.0304; n = 7, 6), and between high avoiders receiving
scrambled versus htr2c shRNA (14.17 ± 4.053 vs. 75.14 ± 25.57, p = 0.0049; n = 6, 7; Fig. 5.2H).
The same analysis found no differences between groups in the number of inactive lever presses
emitted during reinstatement (Fig. 5.3F). Hence, RMTg 5-HT2CR modulation of cocaine aversion
may drive individual differences in propensity to pursue cocaine both in early acquisition and in
subsequent relapse, two of the major determinants of susceptibility to drug addiction.

5.3 Discussion
Prior studies implicated the serotonin system in opposing cocaine’s reinforcing property
by manipulating serotonin level or 5-HT2CR agonism experimentally (Carroll et al. 1990b, Roberts
et al. 1994, Cunningham et al. 2011, Fletcher et al. 2004, Fletcher et al. 2002, Fletcher et al.
2008, Harvey-Lewis et al. 2016, Frankel and Cunningham 2004, McMahon et al. 2001,
Pentkowski et al. 2010, Manvich et al. 2012a, Manvich et al. 2012b, Capriles, Watson and Akil
2012, Craige and Unterwald 2013). Here it is shown 5-HT2CRs at the RMTg are involved in
endogenous neuroadaptations that may determine behavioral or affective response to cocaine.
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Previously using the runway self-administration paradigm, we found while many Sprague
Dawley rats develop progressively increasing latency to obtain cocaine, some individuals never
develop cocaine conditioned avoidance. The divergent phenotypes can be divided into two
groups based on a median of 256 seconds in a bimodal distribution of runway latencies
(Parrilla-Carrero et al. 2021). Adding to our prior findings that showed at the RMTg low and high
avoiders are characterized by decreased expression of calcium permeable AMPA receptors and
higher presynaptic glutamate release respectively, we found in this study RMTg neurons of low
avoiders exhibit a much weaker response, in terms of induced inward current, to ex vivo
application of 5-HT2CR agonist than those of high avoiders. Since RMTg neurons from cocainenaïve and high-avoider animals show similar response to 5-HT2CR agonist, it appears in low
avoiders downregulation of 5-HT2CR expression or function at the RMTg occurs concomitantly or
as a consequence of behavioral adaptation in the runway paradigm and cocaine exposure. The
exact mechanism of regulation may exist at the level of translation, trafficking or sequestration
of cell surface receptors, or intracellular signaling, and it remains to be identified the genetic
and environmental variables that predispose and contribute to the emergence of phenotype
specific neuroadaptations.
Ettenberg 2015 found escalation in cocaine consumption is correlated positively with
conditioned place preference but negatively with runway latency, suggesting rewarding and
aversive properties of cocaine may enhance and deter drug taking, respectively. We found
here, in principle highly corroborative of the prior study, low avoiders acquire and reinstate
lever-based operant response to cocaine-predictive cues more readily than high avoiders do,
and htr2c knockdown at the RMTg causes animals that had developed a high-avoider
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phenotype from runway trainings to behave like a low avoider in the subsequent lever-based
cocaine self-administration task. While htr2c knockdown had no behavior effects in low
avoiders, which is consistent with the finding in those animals of apparently downregulated
receptor level or function, the ability of htr2c knockdown to reverse behavioral phenotype in
high avoiders substantiates the causal role of 5-HT2CRs at the RMTg in mediating serotonin’s
suppressive effects on cocaine taking and seeking. Altogether these findings demonstrate the
correlation between acute affective response to single cocaine infusions and ad libitum cocaine
taking and seeking. They also lend support to the hypothesis that operant response in the leverbased self-administration paradigm may be modulated by aversive effects of cocaine. In this
study we found effects of runway phenotype and shRNA in acquisition as well as extinction and
reinstatement stages of the cocaine lever-based self-administration paradigm. Due to the
permanent nature of AAV mediated shRNA knockdown, however, it cannot be disambiguated
here whether the extent of extinction and reinstatement to cocaine seeking are a function of
prior operant responses such as those emitted during acquisition or they may be regulated
independently by 5-HT2CRs at the RMTg as well. Future studies may be aimed at using RMTg
site-specific delivery of agonist or antagonist to test the role of 5-HT2CRs at the RMTg in
extinction and reinstatement specifically.
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Fig. 5.1. Divergent behavioral aversive response to cocaine correlates with RMTg neuron
electrophysiological response to cocaine and 5-HT2CR activation. A-B. Based on a previously
established criterion of runway latency 256 seconds, individual rat subjects after runway
operant task training of 7 trials were classified as either low (high cocaine seekers) or high
avoiders (low or reluctant cocaine seekers). C. In response to 5-HT2CR activation by bath
application of agonist Ro60-0175, RMTg neurons from high avoiders responded with induction
of inward current while RMTg neurons from low avoiders did not. D. In response to bath
application of cocaine, RMTg neurons from high avoiders responded with resting membrane
depolarization while RMTg neurons from low avoiders did not. E. Sprague Dawley rats were first
tested on the runway paradigm, classified as either low- or high-avoider, and then each group
was further subdivided to receive AAVs encoding either scrambled or htr2c shRNA to the RMTg,
generating a total of four groups of animals to undergo the lever press based cocaine selfadministration protocol. Figure 5.1A adapted from Parilla-Carrero et al 2021. Figure 5.1(C-D)
experiments conceived, designed, performed, and data obtained by JPC.
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Fig. 5.2. The roles of aversive response to cocaine and RMTg 5-HT2CRs in acquisition and
reinstatement of lever press cocaine-seeking. A. During acquisition, high avoiders obtained less
cocaine infusions, and htr2c shRNA at the RMTg increased the number of cocaine infusions in
high but not low avoiders. *p = 0.0320, **p = 0.0067, post hoc pairwise comparisons with Tukey
correction. B. During the first three and last ten cocaine self-administration sessions (median as
shown), high avoiders acquired and escalated cocaine consumption less readily compared to
low avoiders, and htr2c shRNA increased cocaine consumption in high but not in low avoiders.
****p < 0.0001, interaction effect session X runway phenotype X shRNA, repeated measures
three-way ANOVA. C. By the last three self-administration sessions, there is no difference in
cocaine infusions obtained between groups. D. During acquisition, there is a marginal effect of
runway phenotype (p = 0.0533, Mann-Whitney test) on operant responding, and htr2c shRNA
increased lever presses emitted in high but not in low avoiders. High avoiders scrambled (solid
red squares) versus htr2c (hollow red squares) shRNA: *p = 0.0103, htr2c shRNA low (hollow
gray triangles) versus high (hollow red squares) avoiders: *p = 0.0198, post hoc pairwise
comparisons with Tukey correction. E. During the first three and last ten cocaine selfadministration sessions (median as shown), high avoiders acquired and escalated operant
responding for cocaine less readily compared to low avoiders, and htr2c shRNA increased
operant responding in high but not in low avoiders. ***p = 0.0002, interaction effect session X
runway phenotype X shRNA, repeated measures three-way ANOVA. F. By the last three selfadministration sessions, there is no difference in lever presses emitted between groups. G.
There is no difference between groups in the extinction of operant lever presses over ten
training sessions, median as shown. H. Upon exposure to cocaine related cues (tone and light),
high avoider emitted less lever presses, and htr2c shRNA increased responding in high but not
in low avoiders. *p = 0.0304, **p = 0.0049, post hoc pairwise comparisons with Tukey
correction. Error bars indicate mean ± SEM.
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Fig. 5.3. Variation in aversive response to cocaine and injection of htr2c shRNA to the RMTg
had minimal effect on generalized motoric output that is not goal-or drug-directed. A-B.
average inactive lever presses emitted during the first three (A) and last three (B) selfadministration sessions. *p = 0.0412, post hoc pairwise comparisons with Tukey correction. C-D.
average lever presses emitted per infusion during the first three (C) and last three (D) selfadministration sessions. *p = 0.0382, post hoc pairwise comparisons with Tukey correction. E.
Variation in aversive response to cocaine and injection of htr2c shRNA to the RMTg had no
effect on cocaine induced locomotor activity measured by the number of photobeam breaks. F.
Variation in aversive response to cocaine and injection of htr2c shRNA to the RMTg had no
effect on inactive lever presses emitted during reinstatement test. Error bars indicate mean ±
SEM.
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Chapter 6
Discussion and Future Directions
6.1 The Selective Role or Function of 5-HT2CRs and High Serotonin Level at the RMTg in
Aversive Response to Cocaine
In the present study we demonstrated that htr2c is expressed at high levels in individual
RMTg neurons, and that this receptor mediates cocaine-induced excitatory currents in RMTg
that contribute to conditioned avoidance responses to cocaine. Furthermore, we found that 5HT2CR signaling at RMTg is strong in cocaine-naïve rats and high-avoiders, but markedly reduced
in low-avoider rats, and that blocking signaling at this receptor in RMTg enhances acquisition of
and relapse to cocaine seeking in high-avoider rats. While serotonergic roles in motivational
responses to cocaine are relatively less studied than dopaminergic, they have long been
observed, although specific mechanisms have not been well understood. Prior literature has
implicated serotonin and 5-HT2CRs specifically in opposing cocaine’s reinforcing effects,
although many of these studies used systemic manipulations that preclude the elucidation of
specific brain mechanisms. For example, dietary L-tryptophan, which increases 5HT release,
reduces operant responding for cocaine, while ablation of serotonergic neurons using the toxin
5,7-dihyodroxytryptamine (5,7-DHT) increases such responding (1990 Carroll, 1994 Roberts). In
addition, systemic 5-HT2CR agonist and antagonist administration attenuates and enhances,
respectively, lever-based measures of cocaine self-administration and reinstatement to seeking
after extinction (Fletcher et al. 2002, Fletcher et al. 2008, Cunningham et al. 2011, Gerak et al.
2016, Harvey-Lewis et al. 2016, Manvich et al. 2012a, Manvich et al. 2012b, Ruedi-Bettschen et
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al. 2015). Previously, some studies have attributed serotonin and 5-HT2CR’s behavioral
inhibitory effects to GABAergic neurons of the VTA (Bubar and Cunningham 2007, Bubar et al.
2005, Bubar et al. 2011), but those studies may not have carefully distinguished between the
VTA and adjacent RMTg, which was not described until 2009. They also did not examine exactly
what aspect of cocaine-seeking behavior was being influenced by 5HT2CRs, as infusion of 5HT2CR agonist Ro60-0175 to the VTA reduced both cocaine and food-seeking, as well as cocaineevoked locomotion (McMahon et al. 2001, Fletcher et al. 2004). Our current study, in contrast,
addressed both the anatomical and behavioral specificity of the effects of RMTg 5-HT2CR
functional blockade. We found htr2c knockdown at the RMTg but not VTA or IPN attenuated
cocaine conditioned avoidance. Furthermore, using antagonists or mRNA knockdown to reduce,
rather than increase, 5HT2CR function, our study found effects that were selective for drugseeking versus at least three non-drug tasks, including two tests of food-seeking in the face of
escalating effort or punishment costs, and a test of locomotion in novel environment.
Our current findings add to a significant body of literature that has long conceptualized
serotonin to exert oppositional influence on dopamine. Whereas dopamine has dual roles in
promoting reward and behavioral activation, numerous animal and human studies had noted
complementary serotonin roles in aversive processing and behavioral inhibition (Daw, Kakade
and Dayan 2002, Cools, Nakamura and Daw 2011, Cools, Roberts and Robbins 2008, Boureau
and Dayan 2011, Chamberlain et al. 2006, Bari et al. 2010, den Ouden et al. 2013, den Ouden et
al. 2015, Evers et al. 2005, Roiser et al. 2008, Crockett et al. 2012, Crockett, Clark and Robbins
2009, Geurts et al. 2013). In this report, by demonstrating strong htr2c expression on RMTg
gad1 neurons, we provide a plausible mechanism by which serotonin could oppose dopamine
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function, as the RMTg sends dense direct GABAergic projections to VTA and SNc DA neurons,
encodes negative valence, and plays a critical role in the expression of inhibitory aversive
behaviors such as fear-induced freezing and punishment learning (Jhou et al. 2009a, Jhou et al.
2009b, Vento et al. 2017). In addition, by identifying specific circuits and substrates, we were
able to dissect serotonin’s influence in a more detailed manner, showing that not all DA
functions are always opposed by 5HT. For example, while DA plays roles in both learning and
motor performance, we found that 5-HT2CR antagonists in the RMTg impaired only learning,
and not motor performance and recall or expression aspects of cocaine avoidance. Additionally,
injection of htr2c shRNA to the RMTg increased the number of total level presses emitted
during acquisition and reinstatement of cocaine self-administration, but had neither effect on
non-goal-directed locomotion and responding for inactive lever presses nor operant responding
that is not reinforced by cocaine such as food reward seeking. Hence, serotonin’s aversive
processing and behavioral inhibition effects may be decoupled, and suggest 5-HT2CR function at
the RMTg is selectively evoked by stimuli that induce high serotonergic activity, such as cocaine
administration, but not by stimuli that don’t produce comparably high levels of serotonin.
6.2 5-HT2CRs at the RMTg May Play an Important Role in Serotonin Opposition of the DA
System
Together with prior results, the current findings support the notion that cocaine
exposure produces aversive affects that may drive future avoidant or inhibitory behavior via
activation of 5-HT2CRs at the RMTg, suppression of DA neuron firing at the VTA, and then
reduction of DA level at the NAc. Specifically, at 15-30 minutes after cocaine exposure when
aversive effect is the strongest, RMTg firing rate is the most enhanced (Li et al. 2019, Parrilla-
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Carrero et al. 2021), activation of RMTg induces conditioned place aversion (Jhou et al. 2013,
Smith et al. 2019), stimulation of the RMTg rapidly inhibits 94% of dopamine neurons (2011
Hong), cocaine suppresses DA neuron calcium signals (Wei et al. 2018), suppression of VTA DA
neurons results in conditioned place aversion and reduction in DA level in the nucleus
accumbens (NAc) (Danjo et al. 2014), and systemic manipulation of 5-HT2CR function modulates
DA neuron firing and NAc DA level (Di Matteo et al. 1999, Di Matteo et al. 2000, Di Giovanni et
al. 1999, Rocha et al. 2002, De Deurwaerdere et al. 2004). We report here 80% neurons within
the RMTg boundary express htr2c, and we found almost all VTA-projecting neurons at the
RMTg respond to specific 5-HT2CR agonist Ro60-0175 with induction of inward current. While
previously it was shown 5-HT2CR agonist Ro60-0175 infused to the VTA reduced cocaine
induced DA level at the NAc (Navailles et al. 2008), present findings indicate 5-HT2CRs at the
VTA do not play a significant role in cocaine’s aversive effect in behaving animals. htr2c shRNA
delivered to the VTA had no impact on cocaine conditioned avoidance. In addition, we found
following cocaine exposure, compared to the RMTg, at the VTA there is a smaller percentage of
htr2c neurons that is c-fos positive, and in individual htr2c neurons the density of c-fos is also
significantly less. It is unclear why the activation of RMTg htr2c neurons is preferred or stronger
following cocaine exposure, but both prior and our current findings show at the VTA and RMTg
many htr2c neurons are GABAergic (Bubar and Cunningham 2007, Bubar et al. 2011), and it has
been shown that the LHb, a major source of negative reward signals in DA neurons (Matsumoto
and Hikosaka 2007) and which is activated following cocaine exposure (Jhou et al. 2013), sends
more projections to and make more synapses with GABAergic neurons of the RMTg than those
of the VTA (Brinschwitz et al. 2010, Balcita-Pedicino et al. 2011). To further delineate the exact
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circuit that transduces cocaine’s aversive effect to negative affect, future studies will be critical
to characterize glutamatergic and serotonergic cooperativity in activating RMTg neurons, test
the role of RMTg 5-HT2CR activation in suppression of DA neuron firing and regulation of NAc
DA level following cocaine exposure, and identify neuroadaptive changes at the NAc that are
related to suppression of DA level and aversive memories.
Previous work showed following cocaine exposure, at the NAc there is a rapid initial
increase of DA whereas at the VTA there is a delayed but prolonged suppression of DA neuron
calcium signals accompanied by increased RMTg neuron firing (Wei et al. 2018, Li et al. 2019,
Parrilla-Carrero et al. 2021, Yuen et al. 2021). Prior in vivo recordings have noted that delayed
RMTg activation can persist up to 40 minutes after single iv cocaine infusion, and notably,
serotonin-mediated effects in RMTg in slice were also delayed and prolonged relative to the
bath application of cocaine or 5HT2CR agonist. The time delay of RMTg activation, relative to
cocaine’s rewarding effects, is consistent with the original opponent-process theory that
stipulates that regulation of affective or hedonic states, including ones induced by drugs,
consists of a primary reaction and a subsequent counter-reaction that is delayed in time and
opposite in valence. The counter-reaction is postulated to constrain or oppose the primary
reaction and functions to restore hedonic or affective homeostasis (Solomon and Corbit 1974).
One strong prediction of the current work is that 5-HT2CR activation of RMTg neurons can
mediate this opponent effect, via suppressing DA neuron firing and reducing DA release at
major dopaminergic targets such as the prefrontal cortex, NAc, and dorsal striatum.
6.3 5-HT2CR Function as a Therapeutic Determinant in Cocaine Use Disorder
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The functional selectivity of RMTg 5-HT2CRs to modulate aversive response to cocaine
but not other behavior variables of reinforcer seeking identified here is corroborated by a prior
study of ours that first found cocaine aversion to be a distinctive endophenotype. In 2021
Parilla-Carrero, we showed high- and low cocaine-seeking animals, termed low and high
avoiders, respectively, do not differ in novelty-induced locomotion, open arm preference in
elevated plus maze, and motivation to obtain food given the costs of punishment or effort.
Here we built on the prior study by showing individual differences in aversive response to
cocaine predicts the extent of subsequent relapse seeking and identified additional
neuroadaptation at the RMTg that correlates with insensitivity to cocaine’s aversive effect.
Specifically, at the RMTg of low-avoider (high cocaine-seeking) animals, we found 5-HT2CR
function to be downregulated and possibly disabled such that htr2c shRNA aimed at modulating
receptor function had no impact on cocaine taking and seeking behaviors, which is in stark
contrast to the same intervention producing significant effects on operant responding for drug
in high-avoider (low cocaine-seeking) animals. Our investigations utilizing divergent phenotypes
revealed, in addition to cocaine aversive effect per se, sensitivity to cocaine’s aversive effect is
another critical factor to consider for treating cocaine use disorder (CUD). Recently it is
reported, based on data analyzed so far from a phase 2 clinical trial involving human subjects,
as a prospective treatment for CUD parenteral 5-HT2CR agonist lorcaserin is not effective at
reducing incidence of relapse (Negus and Banks 2020). Our findings suggest that one reason for
this failure may have been due to these individuals lacking functional 5HT2CRs on critical
protective neural circuits.
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Currently the mechanisms involved in the loss of 5-HT2CR expression or function upon
repeated drug seeking and cocaine exposure are unclear. In addition to our present findings,
there is some but scant evidence that 5-HT2CRs of other circuits, regions, or nuclei implicated in
cocaine seeking undergo similar adaptation in subjects prone to more persistent seeking of
cocaine. Previously 5-HT2CRs at the nucleus accumbens (NAc), medial prefrontal cortex (mPFC),
and the VTA have been implicated in opposing cocaine’s behaviorally reinforcing and
stimulatory effects on the dopamine system. Specifically, infusion of the selective 5-HT2CR
agonist, WAY 161503, into the NAc abolished cocaine’s ability to decrease intracranial selfstimulation threshold (Katsidoni, Apazoglou and Panagis 2011), htr2c shRNA delivered to the
mPFC caused animals to become more impulsive and reactive to cocaine predictive cues
(Anastasio et al. 2014), and direct microinfusion of 5-HT2CR agonist Ro60-0175 to the VTA
reduced cocaine-induced DA outflow in the NAc, cocaine-induced locomotor activity, and
cocaine reinforced lever pressing for drug (Fletcher et al. 2004, Navailles et al. 2008). While
Anastasio et al. showed in the same study membrane protein expression of 5-HT2CRs at the
medial prefrontal cortex (mPFC) was decreased in rats that are more impulsive and reactive to
drug predictive cue, it remains to be examined whether 5-HT2CR expression and receptor
function at the NAc and VTA may become downregulated upon repeated cocaine seeking and
exposure to the drug as well. Theoretically, the reduced expression or function of 5-HT2CRs may
involve a myriad of cellular mechanisms such as transcription, RNA editing, translation, and
signal transduction, but previously the allosteric interaction between the fourth fragment of the
5-HT2CR carboxyl-terminal third intracellular loop (3L4F) and the tumor suppressor phosphatase
and tensin homology deleted on chromosome 10 (PTEN) protein has been the most implicated
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in the regulation of the reinforcing effects of substances of abuse such as nicotine and
tetrahydrocannabinol (Ji et al. 2006). It has been proposed that PTEN, via dephosphorylating
and complexing with the receptor, dampens 5-HT2CR activity, and it has been shown that
blocking 5-HT2CR : PTEN interaction using a peptide that mimics the 5-HT2CR 3L4F enhances 5HT2CR downstream signaling events such as intracellular calcium release (Anastasio et al. 2013).
It remains to be tested the effects of disrupting 5-HT2CR : PTEN interaction on cocaine seeking
and taking behaviors, and a further and more detailed understanding of key structural features
requisite for 5-HT2CR : PTEN interaction may result in the development of peptidomimetic small
compounds and positive allosteric modulators (PAMs) of 5-HT2CRs (Anastasio et al. 2013, Wold
et al. 2019). In summary, downregulation of cell surface 5-HT2CR expression or receptor
function across multiple CNS circuits and behavioral constructs involved in opposing cocaine
seeking may be an important cause of persistent addictive behavior that is recalcitrant to 5HT2CR-focused treatment. Hence, future effort for developing CUD therapies may be aimed at
identifying means for restoring function of these circuits that appears downregulated in a
vulnerable population.
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